125742 45 S211 M5 c4591001 interim ado mth6 randomization
Document text
16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10051317 C4591001 1005 10051317 20OCT2020 20158 BNT162b2 (30 μg) 20OCT2020/ BNT162b2 (30 μg)12NOV2020/ BNT162b2 (30 μg) 10051328 C4591001 1005 10051328 20OCT2020 20159 BNT162b2 (30 μg) 20OCT2020/ BNT162b2 (30 μg)11NOV2020/ BNT162b2 (30 μg) 10051339 C4591001 1005 10051339 21OCT2020 20160 Placebo 21OCT2020/ Placebo 11NOV2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10051410 C4591001 1005 10051410 09DEC2020 20163 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10051412 C4591001 1005 10051412 14DEC2020 22270 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10051413 C4591001 1005 10051413 14DEC2020 22269 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10051414 C4591001 1005 10051414 14DEC2020 22273 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)25JUN2021/ BNT162b2 (30 μg) 10051415 C4591001 1005 10051415 14DEC2020 22274 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10051417 C4591001 1005 10051417 16DEC2020 22785 Placebo 16DEC2020/ Placebo 06JAN2021/ Placebo 20JUL2021/ BNT162b2 (30 μg)13AUG2021/ BNT162b2 (30 μg) 10051418 C4591001 1005 10051418 16DEC2020 22786 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 1 FDA-CBER-2022-5812-0228206 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10051419 C4591001 1005 10051419 16DEC2020 22794 Placebo 16DEC2020/ Placebo 04JAN2021/ Placebo 24FEB2021/ BNT162b2 (30 μg)17MAR2021/ BNT162b2 (30 μg) 10051420 C4591001 1005 10051420 16DEC2020 22792 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10051421 C4591001 1005 10051421 17DEC2020 23097 Placebo 17DEC2020/ Placebo 07JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10051422 C4591001 1005 10051422 17DEC2020 23098 Placebo 17DEC2020/ Placebo 07JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10051424 C4591001 1005 10051424 18DEC2020 23100 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10051425 C4591001 1005 10051425 18DEC2020 23101 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10051427 C4591001 1005 10051427 21DEC2020 23589 Placebo 21DEC2020/ Placebo 11JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10051428 C4591001 1005 10051428 21DEC2020 23596 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10051429 C4591001 1005 10051429 21DEC2020 23597 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10051430 C4591001 1005 10051430 22DEC2020 23600 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 22APR2021/ BNT162b2 (30 μg)13MAY2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 2 FDA-CBER-2022-5812-0228207 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10051431 C4591001 1005 10051431 22DEC2020 23890 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10051436 C4591001 1005 10051436 22DEC2020 23897 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10051437 C4591001 1005 10051437 22DEC2020 23894 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 27MAY2021/ BNT162b2 (30 μg)17JUN2021/ BNT162b2 (30 μg) 10051438 C4591001 1005 10051438 22DEC2020 23892 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 27MAY2021/ BNT162b2 (30 μg)17JUN2021/ BNT162b2 (30 μg) 10051439 C4591001 1005 10051439 22DEC2020 24039 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10051440 C4591001 1005 10051440 22DEC2020 24041 Placebo 22DEC2020/ Placebo 11JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10051441 C4591001 1005 10051441 22DEC2020 24034 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10051444 C4591001 1005 10051444 22DEC2020 24043 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10051445 C4591001 1005 10051445 22DEC2020 24130 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 26MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 10051447 C4591001 1005 10051447 11JAN2021 24134 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 3 FDA-CBER-2022-5812-0228208 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10051448 C4591001 1005 10051448 11JAN2021 24138 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 26MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 10051449 C4591001 1005 10051449 11JAN2021 24137 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10051450 C4591001 1005 10051450 11JAN2021 26654 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10051451 C4591001 1005 10051451 12JAN2021 26655 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 10061183 C4591001 1006 10061183 30NOV2020 20339 Placebo 30NOV2020/ Placebo 07JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10061184 C4591001 1006 10061184 30NOV2020 20340 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10061188 C4591001 1006 10061188 01DEC2020 20341 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10061189 C4591001 1006 10061189 01DEC2020 20348 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10061190 C4591001 1006 10061190 02DEC2020 20638 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10061191 C4591001 1006 10061191 02DEC2020 20640 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 4 FDA-CBER-2022-5812-0228209 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10061196 C4591001 1006 10061196 02DEC2020 20644 Placebo 02DEC2020/ Placebo 21DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10061200 C4591001 1006 10061200 03DEC2020 20647 Placebo 03DEC2020/ Placebo 24DEC2020/ Placebo 16MAR2021/ BNT162b2 (30 μg)07APR2021/ BNT162b2 (30 μg) 10061201 C4591001 1006 10061201 03DEC2020 20867 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)24DEC2020/ BNT162b2 (30 μg) 10061203 C4591001 1006 10061203 03DEC2020 20871 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10061206 C4591001 1006 10061206 04DEC2020 20872 Placebo 04DEC2020/ Placebo23DEC2020/ Placebo 10061207 C4591001 1006 10061207 04DEC2020 20874 Placebo 04DEC2020/ Placebo23DEC2020/ Placebo 10061209 C4591001 1006 10061209 04DEC2020 20998 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10061212 C4591001 1006 10061212 04DEC2020 20999 Placebo 04DEC2020/ Placebo 23DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10061213 C4591001 1006 10061213 04DEC2020 21000 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10061214 C4591001 1006 10061214 04DEC2020 21001 Placebo 04DEC2020/ Placebo 23DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)21JUN2021/ BNT162b2 (30 μg) 10061219 C4591001 1006 10061219 07DEC2020 21141 Placebo 07DEC2020/ Placebo 24DEC2020/ Placebo 15JUN2021/ BNT162b2 (30 μg)30JUL2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 5 FDA-CBER-2022-5812-0228210 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10061220 C4591001 1006 10061220 07DEC2020 21143 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10061221 C4591001 1006 10061221 07DEC2020 21147 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10061223 C4591001 1006 10061223 07DEC2020 21152 Placebo 07DEC2020/ Placebo 30DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10061224 C4591001 1006 10061224 07DEC2020 21261 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10061226 C4591001 1006 10061226 07DEC2020 21262 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10061227 C4591001 1006 10061227 07DEC2020 21264 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10061228 C4591001 1006 10061228 08DEC2020 21267 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10061229 C4591001 1006 10061229 08DEC2020 21442 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 18FEB2021/ BNT162b2 (30 μg)11MAR2021/ BNT162b2 (30 μg) 10061230 C4591001 1006 10061230 08DEC2020 21446 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)31DEC2020/ BNT162b2 (30 μg) 10061231 C4591001 1006 10061231 08DEC2020 21448 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 6 FDA-CBER-2022-5812-0228211 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10061232 C4591001 1006 10061232 08DEC2020 21450 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10061233 C4591001 1006 10061233 08DEC2020 21561 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10061234 C4591001 1006 10061234 09DEC2020 21563 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10061235 C4591001 1006 10061235 09DEC2020 21568 Placebo 09DEC2020/ Placebo 30DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10061236 C4591001 1006 10061236 09DEC2020 21571 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10061237 C4591001 1006 10061237 09DEC2020 21696 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10061239 C4591001 1006 10061239 09DEC2020 21699 Placebo 09DEC2020/ Placebo 30DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10061241 C4591001 1006 10061241 09DEC2020 21702 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10061242 C4591001 1006 10061242 09DEC2020 21704 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10061243 C4591001 1006 10061243 10DEC2020 21864 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 7 FDA-CBER-2022-5812-0228212 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10061244 C4591001 1006 10061244 10DEC2020 21865 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10061245 C4591001 1006 10061245 10DEC2020 21869 Placebo 10DEC2020/ Placebo 29DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10061247 C4591001 1006 10061247 10DEC2020 21871 Placebo 10DEC2020/ Placebo 29DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10061248 C4591001 1006 10061248 11DEC2020 22046 Placebo 11DEC2020/ Placebo 30DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10061249 C4591001 1006 10061249 11DEC2020 22047 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)31DEC2020/ BNT162b2 (30 μg) 10061250 C4591001 1006 10061250 11DEC2020 22050 Placebo 11DEC2020/ Placebo 31DEC2020/ Placebo 20MAY2021/ BNT162b2 (30 μg)28JUN2021/ BNT162b2 (30 μg) 10061252 C4591001 1006 10061252 11DEC2020 22051 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)31DEC2020/ BNT162b2 (30 μg) 10061253 C4591001 1006 10061253 11DEC2020 22173 Placebo 11DEC2020/ Placebo 30DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10061254 C4591001 1006 10061254 11DEC2020 22174 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10061256 C4591001 1006 10061256 11DEC2020 22176 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 8 FDA-CBER-2022-5812-0228213 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10061257 C4591001 1006 10061257 11DEC2020 22182 Placebo 11DEC2020/ Placebo 30DEC2020/ Placebo 19FEB2021/ BNT162b2 (30 μg)12MAR2021/ BNT162b2 (30 μg) 10061258 C4591001 1006 10061258 14DEC2020 22296 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10061259 C4591001 1006 10061259 14DEC2020 22300 Placebo 14DEC2020/ Placebo 05JAN2021/ Placebo 19MAR2021/ BNT162b2 (30 μg)13APR2021/ BNT162b2 (30 μg) 10061260 C4591001 1006 10061260 14DEC2020 22302 Placebo 14DEC2020/ Placebo 05JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10061261 C4591001 1006 10061261 14DEC2020 22303 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10061262 C4591001 1006 10061262 14DEC2020 22426 Placebo 14DEC2020/ Placebo 06JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)07JUL2021/ BNT162b2 (30 μg) 10061263 C4591001 1006 10061263 14DEC2020 22428 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10061264 C4591001 1006 10061264 14DEC2020 22429 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10061265 C4591001 1006 10061265 18DEC2020 23313 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10061266 C4591001 1006 10061266 15DEC2020 22433 Placebo 15DEC2020/ Placebo 06JAN2021/ Placebo 24FEB2021/ BNT162b2 (30 μg)17MAR2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 9 FDA-CBER-2022-5812-0228214 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10061267 C4591001 1006 10061267 15DEC2020 22558 Placebo 15DEC2020/ Placebo 22JAN2021/ Placebo 21JUL2021/ BNT162b2 (30 μg)13AUG2021/ BNT162b2 (30 μg) 10061269 C4591001 1006 10061269 15DEC2020 22561 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10061270 C4591001 1006 10061270 16DEC2020 22562 Placebo 16DEC2020/ Placebo 06JAN2021/ Placebo 18FEB2021/ BNT162b2 (30 μg)11MAR2021/ BNT162b2 (30 μg) 10061271 C4591001 1006 10061271 16DEC2020 22566 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10061272 C4591001 1006 10061272 16DEC2020 22821 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg) 10061273 C4591001 1006 10061273 16DEC2020 22823 Placebo 16DEC2020/ Placebo 08JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10061274 C4591001 1006 10061274 16DEC2020 22830 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10061276 C4591001 1006 10061276 17DEC2020 22831 Placebo 17DEC2020/ Placebo 06JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10061277 C4591001 1006 10061277 17DEC2020 23159 Placebo 17DEC2020/ Placebo 08JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10061278 C4591001 1006 10061278 17DEC2020 23162 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 10 FDA-CBER-2022-5812-0228215 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10061279 C4591001 1006 10061279 17DEC2020 23166 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10061280 C4591001 1006 10061280 17DEC2020 23168 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 10061282 C4591001 1006 10061282 18DEC2020 23314 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10061283 C4591001 1006 10061283 18DEC2020 23315 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10061284 C4591001 1006 10061284 18DEC2020 23318 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10061285 C4591001 1006 10061285 21DEC2020 23702 Placebo 21DEC2020/ Placebo 12JAN2021/ Placebo 03JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10061286 C4591001 1006 10061286 21DEC2020 23704 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10061287 C4591001 1006 10061287 21DEC2020 23706 Placebo 21DEC2020/ Placebo11JAN2021/ Placebo 10061288 C4591001 1006 10061288 21DEC2020 23708 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10061289 C4591001 1006 10061289 22DEC2020 23941 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10061290 C4591001 1006 10061290 22DEC2020 23943 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 11 FDA-CBER-2022-5812-0228216 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10061291 C4591001 1006 10061291 22DEC2020 23946 Placebo 22DEC2020/ Placebo 13JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10061292 C4591001 1006 10061292 22DEC2020 23948 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10061293 C4591001 1006 10061293 22DEC2020 24050 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10061294 C4591001 1006 10061294 22DEC2020 24054 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10061295 C4591001 1006 10061295 24DEC2020 24056 Placebo 24DEC2020/ Placebo 12JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10061296 C4591001 1006 10061296 29DEC2020 24611 Placebo 29DEC2020/ Placebo19JAN2021/ Placebo 10061297 C4591001 1006 10061297 29DEC2020 24612 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10061298 C4591001 1006 10061298 29DEC2020 24617 Placebo 29DEC2020/ Placebo 20JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10061299 C4591001 1006 10061299 31DEC2020 24618 BNT162b2 (30 μg) 31DEC2020/ BNT162b2 (30 μg)22JAN2021/ BNT162b2 (30 μg) 10061300 C4591001 1006 10061300 07JAN2021 26122 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10071409 C4591001 1007 10071409 22OCT2020 20265 BNT162b2 (30 μg) 22OCT2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 12 FDA-CBER-2022-5812-0228217 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071414 C4591001 1007 10071414 22OCT2020 20268 Placebo 22OCT2020/ Placebo 12NOV2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10071415 C4591001 1007 10071415 22OCT2020 20271 Placebo 22OCT2020/ Placebo10DEC2020/ Placebo 10071417 C4591001 1007 10071417 22OCT2020 20272 BNT162b2 (30 μg) 22OCT2020/ BNT162b2 (30 μg)12NOV2020/ BNT162b2 (30 μg) 10071428 C4591001 1007 10071428 22OCT2020 20292 Placebo 22OCT2020/ Placebo12NOV2020/ Placebo 10071429 C4591001 1007 10071429 22OCT2020 20295 Placebo 22OCT2020/ Placebo12NOV2020/ Placebo 10071467 C4591001 1007 10071467 30NOV2020 20296 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10071469 C4591001 1007 10071469 30NOV2020 20298 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10071471 C4591001 1007 10071471 30NOV2020 20374 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10071472 C4591001 1007 10071472 30NOV2020 20375 Placebo 30NOV2020/ Placebo 21DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10071475 C4591001 1007 10071475 30NOV2020 20378 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10071476 C4591001 1007 10071476 30NOV2020 20446 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 13 FDA-CBER-2022-5812-0228218 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071478 C4591001 1007 10071478 30NOV2020 20384 Placebo 30NOV2020/ Placebo 21DEC2020/ Placebo 20MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10071480 C4591001 1007 10071480 30NOV2020 20447 Placebo 30NOV2020/ Placebo 21DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10071481 C4591001 1007 10071481 01DEC2020 20449 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 07JUN2021/ BNT162b2 (30 μg)28JUN2021/ BNT162b2 (30 μg) 10071482 C4591001 1007 10071482 01DEC2020 20455 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10071483 C4591001 1007 10071483 01DEC2020 20496 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 30MAR2021/ BNT162b2 (30 μg)20APR2021/ BNT162b2 (30 μg) 10071484 C4591001 1007 10071484 01DEC2020 20497 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10071485 C4591001 1007 10071485 01DEC2020 20503 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10071488 C4591001 1007 10071488 01DEC2020 20504 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10071490 C4591001 1007 10071490 01DEC2020 20605 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10071492 C4591001 1007 10071492 01DEC2020 20606 Placebo 01DEC2020/ Placebo21DEC2020/ Placebo 10071494 C4591001 1007 10071494 02DEC2020 20608 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 14 FDA-CBER-2022-5812-0228219 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071495 C4591001 1007 10071495 02DEC2020 20610 Placebo 02DEC2020/ Placebo 22DEC2020/ Placebo 25MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10071496 C4591001 1007 10071496 02DEC2020 20750 Placebo 02DEC2020/ Placebo 22DEC2020/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10071497 C4591001 1007 10071497 02DEC2020 20746 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10071499 C4591001 1007 10071499 03DEC2020 20753 Placebo 03DEC2020/ Placebo22DEC2020/ Placebo 10071500 C4591001 1007 10071500 03DEC2020 20756 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10071504 C4591001 1007 10071504 07DEC2020 21085 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10071505 C4591001 1007 10071505 07DEC2020 21087 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 02JUN2021/ BNT162b2 (30 μg)23JUN2021/ BNT162b2 (30 μg) 10071506 C4591001 1007 10071506 07DEC2020 21089 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10071507 C4591001 1007 10071507 07DEC2020 21090 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10071508 C4591001 1007 10071508 07DEC2020 21192 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10071509 C4591001 1007 10071509 07DEC2020 21197 Placebo 07DEC2020/ Placebo 30DEC2020/ Placebo 20MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 15 FDA-CBER-2022-5812-0228220 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071511 C4591001 1007 10071511 07DEC2020 21198 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10071512 C4591001 1007 10071512 07DEC2020 21276 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10071514 C4591001 1007 10071514 07DEC2020 21199 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10071515 C4591001 1007 10071515 08DEC2020 21283 Placebo 08DEC2020/ Placebo29DEC2020/ Placebo 10071516 C4591001 1007 10071516 08DEC2020 21282 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10071517 C4591001 1007 10071517 08DEC2020 21284 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10071518 C4591001 1007 10071518 08DEC2020 21369 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10071519 C4591001 1007 10071519 08DEC2020 21374 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 31MAR2021/ BNT162b2 (30 μg)21APR2021/ BNT162b2 (30 μg) 10071520 C4591001 1007 10071520 08DEC2020 21375 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 09JUN2021/ BNT162b2 (30 μg)01JUL2021/ BNT162b2 (30 μg) 10071521 C4591001 1007 10071521 08DEC2020 21376 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10071522 C4591001 1007 10071522 08DEC2020 21458 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 26MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 16 FDA-CBER-2022-5812-0228221 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071523 C4591001 1007 10071523 08DEC2020 21453 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10071524 C4591001 1007 10071524 08DEC2020 21462 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 25FEB2021/ BNT162b2 (30 μg)18MAR2021/ BNT162b2 (30 μg) 10071525 C4591001 1007 10071525 08DEC2020 21463 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10071526 C4591001 1007 10071526 08DEC2020 21515 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10071527 C4591001 1007 10071527 08DEC2020 21514 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 03JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10071528 C4591001 1007 10071528 09DEC2020 21521 Placebo 09DEC2020/ Place bo30DEC2020/ Placebo 10071529 C4591001 1007 10071529 09DEC2020 21524 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10071530 C4591001 1007 10071530 09DEC2020 21589 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10071531 C4591001 1007 10071531 09DEC2020 21590 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 25MAY2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10071533 C4591001 1007 10071533 09DEC2020 21591 Placebo 09DEC2020/ Placebo 30DEC2020/ Placebo 26MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 10071535 C4591001 1007 10071535 09DEC2020 21596 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 17 FDA-CBER-2022-5812-0228222 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071536 C4591001 1007 10071536 09DEC2020 21681 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10071537 C4591001 1007 10071537 09DEC2020 21683 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10071539 C4591001 1007 10071539 09DEC2020 21689 Placebo 09DEC2020/ Placebo 30DEC2020/ Placebo 02JUN2021/ BNT162b2 (30 μg)23JUN2021/ BNT162b2 (30 μg) 10071540 C4591001 1007 10071540 09DEC2020 21685 Placebo 09DEC2020/ Placebo 30DEC2020/ Placebo 02JUN2021/ BNT162b2 (30 μg)23JUN2021/ BNT162b2 (30 μg) 10071541 C4591001 1007 10071541 09DEC2020 21767 Placebo 09DEC2020/ Placebo 30DEC2020/ Placebo 09FEB2021/ BNT162b2 (30 μg)02MAR2021/ BNT162b2 (30 μg) 10071542 C4591001 1007 10071542 09DEC2020 21769 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10071543 C4591001 1007 10071543 09DEC2020 21771 Placebo 09DEC2020/ Placebo30DEC2020/ Placebo 10071544 C4591001 1007 10071544 09DEC2020 21773 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10071546 C4591001 1007 10071546 10DEC2020 21827 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10071547 C4591001 1007 10071547 10DEC2020 21830 Placebo 10DEC2020/ Placebo 30DEC2020/ Placebo 20MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10071550 C4591001 1007 10071550 10DEC2020 21832 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 18 FDA-CBER-2022-5812-0228223 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071551 C4591001 1007 10071551 10DEC2020 21835 Placebo 10DEC2020/ Placebo 29DEC2020/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10071552 C4591001 1007 10071552 10DEC2020 21976 Placebo 10DEC2020/ Placebo 29DEC2020/ Placebo 26MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 10071554 C4591001 1007 10071554 10DEC2020 21977 Placebo 10DEC2020/ Placebo30DEC2020/ Placebo 10071555 C4591001 1007 10071555 10DEC2020 21979 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10071557 C4591001 1007 10071557 14DEC2020 21980 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10071558 C4591001 1007 10071558 14DEC2020 22284 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10071559 C4591001 1007 10071559 14DEC2020 22285 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 27MAY2021/ BNT162b2 (30 μg)17JUN2021/ BNT162b2 (30 μg) 10071560 C4591001 1007 10071560 14DEC2020 22286 Placebo 14DEC2020/ Placebo 05JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10071561 C4591001 1007 10071561 14DEC2020 22288 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10071562 C4591001 1007 10071562 14DEC2020 22385 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10071563 C4591001 1007 10071563 14DEC2020 22386 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 19 FDA-CBER-2022-5812-0228224 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071564 C4591001 1007 10071564 14DEC2020 22387 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10071565 C4591001 1007 10071565 14DEC2020 22388 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10071566 C4591001 1007 10071566 14DEC2020 22402 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10071567 C4591001 1007 10071567 15DEC2020 22407 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10071568 C4591001 1007 10071568 15DEC2020 22409 Placebo 15DEC2020/ Placebo 05JAN2021/ Placebo 01JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10071569 C4591001 1007 10071569 15DEC2020 22411 Placebo 15DEC2020/ Placebo 05JAN2021/ Placebo 03JUN2021/ BNT162b2 (30 μg)23JUN2021/ BNT162b2 (30 μg) 10071570 C4591001 1007 10071570 15DEC2020 22521 Placebo 15DEC2020/ Placebo 05JAN2021/ Placebo 03JUN2021/ BNT162b2 (30 μg)23JUN2021/ BNT162b2 (30 μg) 10071571 C4591001 1007 10071571 15DEC2020 22528 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10071572 C4591001 1007 10071572 15DEC2020 22529 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10071573 C4591001 1007 10071573 15DEC2020 22532 Placebo 15DEC2020/ Placebo04JAN2021/ Placebo 10071574 C4591001 1007 10071574 16DEC2020 22727 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 20 FDA-CBER-2022-5812-0228225 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071575 C4591001 1007 10071575 16DEC2020 22728 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10071576 C4591001 1007 10071576 16DEC2020 22733 Placebo 16DEC2020/ Placebo 06JAN2021/ Placebo 12MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10071577 C4591001 1007 10071577 16DEC2020 22918 Placebo 16DEC2020/ Placebo 06JAN2021/ Placebo 19APR2021/ BNT162b2 (30 μg)11MAY2021/ BNT162b2 (30 μg) 10071578 C4591001 1007 10071578 16DEC2020 22736 Placebo 16DEC2020/ Placebo 06JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10071579 C4591001 1007 10071579 16DEC2020 22920 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10071580 C4591001 1007 10071580 16DEC2020 22921 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10071581 C4591001 1007 10071581 17DEC2020 22928 Placebo 17DEC2020/ Placebo 07JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10071582 C4591001 1007 10071582 17DEC2020 23087 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 10071583 C4591001 1007 10071583 17DEC2020 23146 Placebo 17DEC2020/ Placebo 07JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10071584 C4591001 1007 10071584 17DEC2020 23091 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 21 FDA-CBER-2022-5812-0228226 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071585 C4591001 1007 10071585 17DEC2020 23094 Placebo 17DEC2020/ Placebo 07JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10071586 C4591001 1007 10071586 17DEC2020 23096 Placebo 17DEC2020/ Placebo 07JAN2021/ Placebo 01JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10071587 C4591001 1007 10071587 17DEC2020 23148 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 10071588 C4591001 1007 10071588 28DEC2020 23151 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10071589 C4591001 1007 10071589 28DEC2020 23155 Placebo 28DEC2020/ Placebo 19JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10071590 C4591001 1007 10071590 28DEC2020 24372 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10071591 C4591001 1007 10071591 28DEC2020 24378 Placebo 28DEC2020/ Placebo 19JAN2021/ Placebo 02JUN2021/ BNT162b2 (30 μg)23JUN2021/ BNT162b2 (30 μg) 10071592 C4591001 1007 10071592 28DEC2020 24377 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071593 C4591001 1007 10071593 28DEC2020 24380 Placebo 28DEC2020/ Placebo 10071594 C4591001 1007 10071594 28DEC2020 24453 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071595 C4591001 1007 10071595 28DEC2020 24454 Placebo 28DEC2020/ Placebo 19JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 22 FDA-CBER-2022-5812-0228227 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071596 C4591001 1007 10071596 28DEC2020 24456 Placebo 28DEC2020/ Placebo 20JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10071597 C4591001 1007 10071597 28DEC2020 24460 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071599 C4591001 1007 10071599 28DEC2020 24478 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071600 C4591001 1007 10071600 28DEC2020 24479 Placebo 28DEC2020/ Placebo 19JAN2021/ Placebo 01JUN2021/ BNT162b2 (30 μg)14JUL2021/ BNT162b2 (30 μg) 10071601 C4591001 1007 10071601 28DEC2020 24481 Placebo 28DEC2020/ Placebo19JAN2021/ Placebo 10071602 C4591001 1007 10071602 28DEC2020 24483 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071603 C4591001 1007 10071603 29DEC2020 24539 Placebo 29DEC2020/ Placebo19JAN2021/ Placebo 10071604 C4591001 1007 10071604 29DEC2020 24538 Placebo 29DEC2020/ Placebo19JAN2021/ Placebo 10071605 C4591001 1007 10071605 29DEC2020 24544 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071606 C4591001 1007 10071606 29DEC2020 24545 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071607 C4591001 1007 10071607 29DEC2020 24683 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 23 FDA-CBER-2022-5812-0228228 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071608 C4591001 1007 10071608 29DEC2020 24684 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10071609 C4591001 1007 10071609 29DEC2020 24685 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071610 C4591001 1007 10071610 29DEC2020 24730 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10071612 C4591001 1007 10071612 29DEC2020 24692 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071613 C4591001 1007 10071613 29DEC2020 24732 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10071614 C4591001 1007 10071614 29DEC2020 24734 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)28JUN2021/ BNT162b2 (30 μg) 10071615 C4591001 1007 10071615 29DEC2020 24740 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071616 C4591001 1007 10071616 29DEC2020 24777 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10071617 C4591001 1007 10071617 29DEC2020 24781 Placebo 29DEC2020/ Placebo 20JAN2021/ Placebo 19APR2021/ BNT162b2 (30 μg)10MAY2021/ BNT162b2 (30 μg) 10071618 C4591001 1007 10071618 29DEC2020 24784 Placebo 29DEC2020/ Placebo19JAN2021/ Placebo 10071619 C4591001 1007 10071619 30DEC2020 24785 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 24 FDA-CBER-2022-5812-0228229 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071620 C4591001 1007 10071620 30DEC2020 24828 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10071621 C4591001 1007 10071621 30DEC2020 24830 Placebo 30DEC2020/ Placebo20JAN2021/ Placebo 10071622 C4591001 1007 10071622 30DEC2020 24831 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg) 10071623 C4591001 1007 10071623 30DEC2020 24832 Placebo 30DEC2020/ Placebo 21JAN2021/ Placebo 01JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10071624 C4591001 1007 10071624 30DEC2020 24910 Placebo 30DEC2020/ Placebo 26JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10071625 C4591001 1007 10071625 30DEC2020 24915 Placebo 30DEC2020/ Placebo 26JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10071626 C4591001 1007 10071626 30DEC2020 24917 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10071627 C4591001 1007 10071627 30DEC2020 24919 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10071628 C4591001 1007 10071628 30DEC2020 24997 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10071629 C4591001 1007 10071629 30DEC2020 24994 Placebo 30DEC2020/ Placebo 20JAN2021/ Placebo 01JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10071630 C4591001 1007 10071630 30DEC2020 24993 Placebo 30DEC2020/ Placebo 20JAN2021/ Placebo 01JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 25 FDA-CBER-2022-5812-0228230 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071631 C4591001 1007 10071631 30DEC2020 25003 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10071632 C4591001 1007 10071632 30DEC2020 25062 Placebo 30DEC2020/ Placebo 21JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10071633 C4591001 1007 10071633 30DEC2020 25058 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10071634 C4591001 1007 10071634 04JAN2021 25064 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10071635 C4591001 1007 10071635 04JAN2021 25063 Placebo 04JAN2021/ Placebo25JAN2021/ Placebo 10071636 C4591001 1007 10071636 04JAN2021 25149 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10071638 C4591001 1007 10071638 04JAN2021 25153 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10071639 C4591001 1007 10071639 04JAN2021 25154 Placebo 04JAN2021/ Placebo25JAN2021/ Placebo 10071640 C4591001 1007 10071640 04JAN2021 25156 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 03JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10071641 C4591001 1007 10071641 04JAN2021 25202 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10071642 C4591001 1007 10071642 04JAN2021 25205 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 26 FDA-CBER-2022-5812-0228231 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071643 C4591001 1007 10071643 04JAN2021 25204 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 27MAY2021/ BNT162b2 (30 μg)24JUN2021/ BNT162b2 (30 μg) 10071644 C4591001 1007 10071644 04JAN2021 25294 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10071645 C4591001 1007 10071645 04JAN2021 25208 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 26MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 10071646 C4591001 1007 10071646 04JAN2021 25299 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 03JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10071647 C4591001 1007 10071647 04JAN2021 25302 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10071648 C4591001 1007 10071648 05JAN2021 25304 Placebo 05JAN2021/ Placebo 26JAN2021/ Placebo 20APR2021/ BNT162b2 (30 μg)11MAY2021/ BNT162b2 (30 μg) 10071649 C4591001 1007 10071649 05JAN2021 25369 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10071650 C4591001 1007 10071650 05JAN2021 25370 Placebo 05JAN2021/ Placebo 26JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10071651 C4591001 1007 10071651 05JAN2021 25373 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10071652 C4591001 1007 10071652 05JAN2021 25376 Placebo 05JAN2021/ Placebo 26JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)21JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 27 FDA-CBER-2022-5812-0228232 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10071653 C4591001 1007 10071653 05JAN2021 25437 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10071654 C4591001 1007 10071654 05JAN2021 25443 Placebo 05JAN2021/ Placebo26JAN2021/ Placebo 10071655 C4591001 1007 10071655 06JAN2021 25445 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10071656 C4591001 1007 10071656 06JAN2021 25448 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10071658 C4591001 1007 10071658 06JAN2021 25838 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10071659 C4591001 1007 10071659 06JAN2021 25834 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10071660 C4591001 1007 10071660 06JAN2021 25833 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 02JUN2021/ BNT162b2 (30 μg)24JUN2021/ BNT162b2 (30 μg) 10071661 C4591001 1007 10071661 07JAN2021 25840 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10071662 C4591001 1007 10071662 07JAN2021 26061 Placebo 07JAN2021/ Placebo28JAN2021/ Placebo 10081751 C4591001 1008 10081751 01DEC2020 20520 Placebo 01DEC2020/ Placebo 23DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081752 C4591001 1008 10081752 01DEC2020 20525 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 28 FDA-CBER-2022-5812-0228233 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081753 C4591001 1008 10081753 01DEC2020 20521 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10081754 C4591001 1008 10081754 02DEC2020 20527 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10081755 C4591001 1008 10081755 02DEC2020 20702 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10081756 C4591001 1008 10081756 02DEC2020 20704 Placebo 02DEC2020/ Placebo 22DEC2020/ Placebo 22APR2021/ BNT162b2 (30 μg)12MAY2021/ BNT162b2 (30 μg) 10081757 C4591001 1008 10081757 02DEC2020 20705 Placebo 02DEC2020/ Placebo 22DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10081758 C4591001 1008 10081758 02DEC2020 20707 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10081760 C4591001 1008 10081760 07DEC2020 21257 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10081761 C4591001 1008 10081761 07DEC2020 21256 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 05APR2021/ BNT162b2 (30 μg)27APR2021/ BNT162b2 (30 μg) 10081763 C4591001 1008 10081763 07DEC2020 21260 Placebo 07DEC2020/ Placebo 30DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10081764 C4591001 1008 10081764 07DEC2020 21258 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 29 FDA-CBER-2022-5812-0228234 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081767 C4591001 1008 10081767 08DEC2020 21468 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081768 C4591001 1008 10081768 08DEC2020 21469 Placebo 08DEC2020/ Placebo29DEC2020/ Placebo 10081769 C4591001 1008 10081769 08DEC2020 21475 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10081770 C4591001 1008 10081770 09DEC2020 21476 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10081771 C4591001 1008 10081771 09DEC2020 21662 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10081773 C4591001 1008 10081773 09DEC2020 21664 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081774 C4591001 1008 10081774 09DEC2020 21668 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10081775 C4591001 1008 10081775 09DEC2020 21667 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 21MAY2021/ BNT162b2 (30 μg)18JUN2021/ BNT162b2 (30 μg) 10081777 C4591001 1008 10081777 10DEC2020 21873 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)31DEC2020/ BNT162b2 (30 μg) 10081780 C4591001 1008 10081780 10DEC2020 21875 Placebo 10DEC2020/ Placebo 29DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10081781 C4591001 1008 10081781 10DEC2020 21878 Placebo 10DEC2020/ Placebo 31DEC2020/ Placebo 20MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 30 FDA-CBER-2022-5812-0228235 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081785 C4591001 1008 10081785 11DEC2020 21880 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10081788 C4591001 1008 10081788 14DEC2020 22317 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081789 C4591001 1008 10081789 14DEC2020 22321 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10081790 C4591001 1008 10081790 14DEC2020 22322 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081791 C4591001 1008 10081791 14DEC2020 22357 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10081792 C4591001 1008 10081792 14DEC2020 22323 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10081793 C4591001 1008 10081793 14DEC2020 22359 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081794 C4591001 1008 10081794 14DEC2020 22358 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081795 C4591001 1008 10081795 15DEC2020 22363 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 10081796 C4591001 1008 10081796 15DEC2020 22570 Placebo 15DEC2020/ Placebo 05JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 31 FDA-CBER-2022-5812-0228236 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081797 C4591001 1008 10081797 15DEC2020 22574 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10081798 C4591001 1008 10081798 15DEC2020 22575 Placebo 15DEC2020/ Placebo 05JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081799 C4591001 1008 10081799 15DEC2020 22577 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10081800 C4591001 1008 10081800 16DEC2020 22775 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10081801 C4591001 1008 10081801 17DEC2020 22776 Placebo 17DEC2020/ Placebo 08JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10081802 C4591001 1008 10081802 17DEC2020 22780 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 10081803 C4591001 1008 10081803 17DEC2020 22783 Placebo 17DEC2020/ Placebo 07JAN2021/ Placebo 19MAR2021/ BNT162b2 (30 μg)09APR2021/ BNT162b2 (30 μg) 10081804 C4591001 1008 10081804 17DEC2020 23122 Placebo 17DEC2020/ Placebo 07JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081805 C4591001 1008 10081805 17DEC2020 23123 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 10081806 C4591001 1008 10081806 17DEC2020 23127 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 32 FDA-CBER-2022-5812-0228237 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081807 C4591001 1008 10081807 18DEC2020 23129 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081808 C4591001 1008 10081808 18DEC2020 23301 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10081809 C4591001 1008 10081809 18DEC2020 23306 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081810 C4591001 1008 10081810 18DEC2020 23307 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10081811 C4591001 1008 10081811 18DEC2020 23308 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10081812 C4591001 1008 10081812 18DEC2020 23385 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081813 C4591001 1008 10081813 18DEC2020 23392 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10081814 C4591001 1008 10081814 18DEC2020 23394 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10081815 C4591001 1008 10081815 18DEC2020 23396 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10081816 C4591001 1008 10081816 18DEC2020 23412 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 33 FDA-CBER-2022-5812-0228238 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081817 C4591001 1008 10081817 18DEC2020 23413 Placebo 18DEC2020/ Placebo 06JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081818 C4591001 1008 10081818 18DEC2020 23415 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10081819 C4591001 1008 10081819 21DEC2020 23418 Placebo 21DEC2020/ Placebo 11JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10081820 C4591001 1008 10081820 21DEC2020 23629 Placebo 21DEC2020/ Placebo 11JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10081821 C4591001 1008 10081821 21DEC2020 23634 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10081822 C4591001 1008 10081822 21DEC2020 23635 Placebo 21DEC2020/ Placebo 11JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081823 C4591001 1008 10081823 21DEC2020 23636 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10081824 C4591001 1008 10081824 21DEC2020 23654 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10081825 C4591001 1008 10081825 21DEC2020 23656 Placebo 21DEC2020/ Placebo 11JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081826 C4591001 1008 10081826 21DEC2020 23659 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 34 FDA-CBER-2022-5812-0228239 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081827 C4591001 1008 10081827 21DEC2020 23821 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10081828 C4591001 1008 10081828 21DEC2020 23660 Placebo 21DEC2020/ Placebo 22JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10081829 C4591001 1008 10081829 22DEC2020 23824 Placebo 22DEC2020/ Placebo12JAN2021/ Placebo 10081830 C4591001 1008 10081830 22DEC2020 23825 Placebo 22DEC2020/ Placebo 13JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10081831 C4591001 1008 10081831 22DEC2020 23827 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10081832 C4591001 1008 10081832 22DEC2020 23986 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10081833 C4591001 1008 10081833 22DEC2020 23988 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081834 C4591001 1008 10081834 22DEC2020 23991 Placebo 22DEC2020/ Placebo13JAN2021/ Placebo 10081835 C4591001 1008 10081835 22DEC2020 23993 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10081836 C4591001 1008 10081836 22DEC2020 24088 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081837 C4591001 1008 10081837 22DEC2020 24089 Placebo 22DEC2020/ Placebo 12JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 35 FDA-CBER-2022-5812-0228240 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081838 C4591001 1008 10081838 22DEC2020 24090 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10081839 C4591001 1008 10081839 22DEC2020 24091 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10081840 C4591001 1008 10081840 23DEC2020 24193 Placebo 23DEC2020/ Placebo 13JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081841 C4591001 1008 10081841 23DEC2020 24195 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10081842 C4591001 1008 10081842 23DEC2020 24196 Placebo 23DEC2020/ Placebo 12JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10081843 C4591001 1008 10081843 23DEC2020 24198 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10081844 C4591001 1008 10081844 23DEC2020 24201 Placebo 23DEC2020/ Placebo 13JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10081845 C4591001 1008 10081845 23DEC2020 24207 Placebo 23DEC2020/ Placebo 11JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10081846 C4591001 1008 10081846 23DEC2020 24212 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10081847 C4591001 1008 10081847 23DEC2020 24206 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 36 FDA-CBER-2022-5812-0228241 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081848 C4591001 1008 10081848 23DEC2020 24216 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)14JAN2021/ BNT162b2 (30 μg) 10081849 C4591001 1008 10081849 23DEC2020 24219 Placebo 23DEC2020/ Placebo 14JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081850 C4591001 1008 10081850 23DEC2020 24221 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)14JAN2021/ BNT162b2 (30 μg) 10081851 C4591001 1008 10081851 23DEC2020 24222 Placebo 23DEC2020/ Placebo 15JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10081852 C4591001 1008 10081852 23DEC2020 24249 Placebo 23DEC2020/ Placebo 15JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10081853 C4591001 1008 10081853 28DEC2020 24250 Placebo 28DEC2020/ Placebo 18JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10081854 C4591001 1008 10081854 28DEC2020 24253 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10081855 C4591001 1008 10081855 28DEC2020 24257 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10081856 C4591001 1008 10081856 28DEC2020 24395 Placebo 28DEC2020/ Placebo 18JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10081857 C4591001 1008 10081857 28DEC2020 24396 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 37 FDA-CBER-2022-5812-0228242 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081858 C4591001 1008 10081858 28DEC2020 24397 Placebo 28DEC2020/ Placebo 19JAN2021/ Placebo 17FEB2021/ BNT162b2 (30 μg)08MAR2021/ BNT162b2 (30 μg) 10081859 C4591001 1008 10081859 28DEC2020 24402 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10081860 C4591001 1008 10081860 28DEC2020 24465 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10081861 C4591001 1008 10081861 29DEC2020 24469 Placebo 29DEC2020/ Placebo 18JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10081862 C4591001 1008 10081862 29DEC2020 24471 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10081863 C4591001 1008 10081863 29DEC2020 24472 Placebo 29DEC2020/ Placebo 18JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10081864 C4591001 1008 10081864 29DEC2020 24639 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10081865 C4591001 1008 10081865 29DEC2020 24641 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10081866 C4591001 1008 10081866 29DEC2020 24644 Placebo 29DEC2020/ Placebo 18JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081867 C4591001 1008 10081867 29DEC2020 24642 Placebo 29DEC2020/ Placebo 18JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 38 FDA-CBER-2022-5812-0228243 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081868 C4591001 1008 10081868 29DEC2020 24765 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10081869 C4591001 1008 10081869 29DEC2020 24766 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10081870 C4591001 1008 10081870 29DEC2020 24775 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10081871 C4591001 1008 10081871 30DEC2020 24776 Placebo 30DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081872 C4591001 1008 10081872 30DEC2020 24885 Placebo 30DEC2020/ Placebo 22JAN2021/ Placebo 09APR2021/ BNT162b2 (30 μg)28APR2021/ BNT162b2 (30 μg) 10081873 C4591001 1008 10081873 30DEC2020 24891 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10081874 C4591001 1008 10081874 30DEC2020 24895 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10081875 C4591001 1008 10081875 30DEC2020 24893 Placebo 30DEC2020/ Placebo 20JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081876 C4591001 1008 10081876 30DEC2020 24982 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10081877 C4591001 1008 10081877 30DEC2020 24983 Placebo 30DEC2020/ Placebo 20JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 39 FDA-CBER-2022-5812-0228244 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081878 C4591001 1008 10081878 30DEC2020 24984 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10081879 C4591001 1008 10081879 30DEC2020 24989 Placebo 30DEC2020/ Placebo20JAN2021/ Placebo 10081880 C4591001 1008 10081880 30DEC2020 25011 Placebo 30DEC2020/ Placebo 19JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10081881 C4591001 1008 10081881 30DEC2020 25009 Placebo 30DEC2020/ Placebo 19JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10081882 C4591001 1008 10081882 31DEC2020 25012 BNT162b2 (30 μg) 31DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10081883 C4591001 1008 10081883 31DEC2020 25016 BNT162b2 (30 μg) 31DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10081884 C4591001 1008 10081884 31DEC2020 25114 Placebo 31DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081885 C4591001 1008 10081885 31DEC2020 25116 BNT162b2 (30 μg) 31DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10081886 C4591001 1008 10081886 31DEC2020 25115 BNT162b2 (30 μg) 31DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10081887 C4591001 1008 10081887 04JAN2021 25121 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081888 C4591001 1008 10081888 04JAN2021 25161 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 40 FDA-CBER-2022-5812-0228245 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081889 C4591001 1008 10081889 04JAN2021 25163 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10081890 C4591001 1008 10081890 04JAN2021 25164 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10081891 C4591001 1008 10081891 04JAN2021 25172 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10081892 C4591001 1008 10081892 04JAN2021 25245 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10081893 C4591001 1008 10081893 04JAN2021 25248 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10081894 C4591001 1008 10081894 04JAN2021 25250 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10081895 C4591001 1008 10081895 04JAN2021 25269 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10081896 C4591001 1008 10081896 04JAN2021 25256 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081897 C4591001 1008 10081897 05JAN2021 25273 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10081898 C4591001 1008 10081898 05JAN2021 25279 Placebo 05JAN2021/ Placebo 25JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 41 FDA-CBER-2022-5812-0228246 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081899 C4591001 1008 10081899 05JAN2021 25274 Placebo 05JAN2021/ Placebo 25JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10081900 C4591001 1008 10081900 05JAN2021 25509 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10081901 C4591001 1008 10081901 05JAN2021 25516 Placebo 05JAN2021/ Placebo 26JAN2021/ Placebo 15FEB2021/ BNT162b2 (30 μg)08MAR2021/ BNT162b2 (30 μg) 10081902 C4591001 1008 10081902 05JAN2021 25518 Placebo 05JAN2021/ Placebo 26JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081903 C4591001 1008 10081903 05JAN2021 25520 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10081904 C4591001 1008 10081904 05JAN2021 25549 Placebo 05JAN2021/ Placebo 26JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081905 C4591001 1008 10081905 06JAN2021 25552 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10081906 C4591001 1008 10081906 06JAN2021 25555 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10081907 C4591001 1008 10081907 06JAN2021 25556 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081908 C4591001 1008 10081908 06JAN2021 25689 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 42 FDA-CBER-2022-5812-0228247 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081909 C4591001 1008 10081909 06JAN2021 25690 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10081910 C4591001 1008 10081910 06JAN2021 25691 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10081911 C4591001 1008 10081911 06JAN2021 25695 Placebo 06JAN2021/ Placebo 28JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081912 C4591001 1008 10081912 06JAN2021 25818 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10081913 C4591001 1008 10081913 06JAN2021 25816 Placebo 06JAN2021/ Placebo 28JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10081914 C4591001 1008 10081914 06JAN2021 25817 Placebo 06JAN2021/ Placebo 12FEB2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10081915 C4591001 1008 10081915 07JAN2021 25820 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10081916 C4591001 1008 10081916 07JAN2021 25929 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10081917 C4591001 1008 10081917 07JAN2021 25931 Placebo 07JAN2021/ Placebo 28JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10081918 C4591001 1008 10081918 07JAN2021 25933 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 43 FDA-CBER-2022-5812-0228248 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081919 C4591001 1008 10081919 07JAN2021 25937 Placebo 07JAN2021/ Placebo 29JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10081920 C4591001 1008 10081920 07JAN2021 26085 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10081921 C4591001 1008 10081921 07JAN2021 26087 Placebo 07JAN2021/ Placebo 29JAN2021/ Placebo 26APR2021/ BNT162b2 (30 μg)17MAY2021/ BNT162b2 (30 μg) 10081922 C4591001 1008 10081922 08JAN2021 26089 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10081923 C4591001 1008 10081923 08JAN2021 26091 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10081924 C4591001 1008 10081924 08JAN2021 26205 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081925 C4591001 1008 10081925 08JAN2021 26209 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10081926 C4591001 1008 10081926 08JAN2021 26216 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081927 C4591001 1008 10081927 08JAN2021 26211 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10081928 C4591001 1008 10081928 08JAN2021 26362 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 44 FDA-CBER-2022-5812-0228249 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081929 C4591001 1008 10081929 08JAN2021 26366 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10081930 C4591001 1008 10081930 11JAN2021 26368 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081931 C4591001 1008 10081931 11JAN2021 26369 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10081932 C4591001 1008 10081932 11JAN2021 26579 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10081933 C4591001 1008 10081933 11JAN2021 26580 Placebo 11JAN2021/ Placebo 02FEB2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10081934 C4591001 1008 10081934 11JAN2021 26587 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10081935 C4591001 1008 10081935 11JAN2021 26588 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 10081936 C4591001 1008 10081936 11JAN2021 26687 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10081937 C4591001 1008 10081937 11JAN2021 26689 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10081938 C4591001 1008 10081938 11JAN2021 26690 Placebo 11JAN2021/ Placebo 02FEB2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 45 FDA-CBER-2022-5812-0228250 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10081940 C4591001 1008 10081940 12JAN2021 26693 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10081941 C4591001 1008 10081941 12JAN2021 26877 Placebo 12JAN2021/ Placebo 02FEB2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081942 C4591001 1008 10081942 12JAN2021 26879 Placebo 12JAN2021/ Placebo 02FEB2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10081943 C4591001 1008 10081943 12JAN2021 26880 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10091204 C4591001 1009 10091204 15OCT2020 20017 Placebo 15OCT2020/ Placebo 03NOV2020/ Placebo 02AUG2021/ BNT162b2 (30 μg)23AUG2021/ BNT162b2 (30 μg) 10091205 C4591001 1009 10091205 15OCT2020 20018 BNT162b2 (30 μg) 15OCT2020/ BNT162b2 (30 μg)06NOV2020/ BNT162b2 (30 μg) 10091208 C4591001 1009 10091208 15OCT2020 20020 Placebo 15OCT2020/ Placebo 06NOV2020/ Placebo 05MAR2021/ BNT162b2 (30 μg)25MAR2021/ BNT162b2 (30 μg) 10091209 C4591001 1009 10091209 15OCT2020 20022 BNT162b2 (30 μg) 15OCT2020/ BNT162b2 (30 μg)04NOV2020/ BNT162b2 (30 μg) 10091212 C4591001 1009 10091212 16OCT2020 20061 Placebo 16OCT2020/ Placebo 16NOV2020/ Placebo 21MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10091213 C4591001 1009 10091213 16OCT2020 20062 Placebo 16OCT2020/ Placebo 04NOV2020/ Placebo 22FEB2021/ BNT162b2 (30 μg)16MAR2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 46 FDA-CBER-2022-5812-0228251 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091216 C4591001 1009 10091216 16OCT2020 20067 BNT162b2 (30 μg) 16OCT2020/ BNT162b2 (30 μg)06NOV2020/ BNT162b2 (30 μg) 10091218 C4591001 1009 10091218 16OCT2020 20072 BNT162b2 (30 μg) 16OCT2020/ BNT162b2 (30 μg)06NOV2020/ BNT162b2 (30 μg) 10091220 C4591001 1009 10091220 19OCT2020 20133 Placebo 19OCT2020/ Placebo07NOV2020/ Placebo 10091221 C4591001 1009 10091221 19OCT2020 20134 BNT162b2 (30 μg) 19OCT2020/ BNT162b2 (30 μg)07NOV2020/ BNT162b2 (30 μg) 10091223 C4591001 1009 10091223 19OCT2020 20139 BNT162b2 (30 μg) 19OCT2020/ BNT162b2 (30 μg)10NOV2020/ BNT162b2 (30 μg) 10091226 C4591001 1009 10091226 20OCT2020 20141 Placebo 20OCT2020/ Placebo 09NOV2020/ Placebo 20MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10091227 C4591001 1009 10091227 20OCT2020 20207 BNT162b2 (30 μg) 20OCT2020/ BNT162b2 (30 μg)10NOV2020/ BNT162b2 (30 μg) 10091229 C4591001 1009 10091229 20OCT2020 20209 Placebo 20OCT2020/ Placebo 21MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10091231 C4591001 1009 10091231 20OCT2020 20210 BNT162b2 (30 μg) 20OCT2020/ BNT162b2 (30 μg)09NOV2020/ BNT162b2 (30 μg) 10091233 C4591001 1009 10091233 21OCT2020 20211 Placebo 21OCT2020/ Placebo 12NOV2020/ Placebo 02JUN2021/ BNT162b2 (30 μg)23JUN2021/ BNT162b2 (30 μg) 10091234 C4591001 1009 10091234 21OCT2020 20245 BNT162b2 (30 μg) 21OCT2020/ BNT162b2 (30 μg)11NOV2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 47 FDA-CBER-2022-5812-0228252 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091237 C4591001 1009 10091237 21OCT2020 20246 Placebo 21OCT2020/ Placebo12NOV2020/ Placebo 10091238 C4591001 1009 10091238 21OCT2020 20251 Placebo 21OCT2020/ Placebo 10NOV2020/ Placebo 26APR2021/ BNT162b2 (30 μg)17MAY2021/ BNT162b2 (30 μg) 10091240 C4591001 1009 10091240 21OCT2020 20252 BNT162b2 (30 μg) 21OCT2020/ BNT162b2 (30 μg)09NOV2020/ BNT162b2 (30 μg) 10091246 C4591001 1009 10091246 22OCT2020 20314 Placebo 22OCT2020/ Placebo 10NOV2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10091247 C4591001 1009 10091247 22OCT2020 20316 BNT162b2 (30 μg) 22OCT2020/ BNT162b2 (30 μg)11NOV2020/ BNT162b2 (30 μg) 10091249 C4591001 1009 10091249 22OCT2020 20320 Placebo 22OCT2020/ Placebo 13NOV2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10091250 C4591001 1009 10091250 22OCT2020 20323 BNT162b2 (30 μg) 22OCT2020/ BNT162b2 (30 μg)13NOV2020/ BNT162b2 (30 μg) 10091265 C4591001 1009 10091265 01DEC2020 20505 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10091266 C4591001 1009 10091266 01DEC2020 20506 Placebo 01DEC2020/ Placebo 21DEC2020/ Placebo 04MAR2021/ BNT162b2 (30 μg)23MAR2021/ BNT162b2 (30 μg) 10091267 C4591001 1009 10091267 01DEC2020 20511 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10091269 C4591001 1009 10091269 01DEC2020 20514 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 48 FDA-CBER-2022-5812-0228253 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091270 C4591001 1009 10091270 01DEC2020 20629 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10091272 C4591001 1009 10091272 02DEC2020 20631 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10091273 C4591001 1009 10091273 02DEC2020 20633 Placebo 02DEC2020/ Placebo 22DEC2020/ Placebo 21MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10091274 C4591001 1009 10091274 02DEC2020 20635 Placebo 02DEC2020/ Placebo 28DEC2020/ Placebo 02JUL2021/ BNT162b2 (30 μg)21JUL2021/ BNT162b2 (30 μg) 10091275 C4591001 1009 10091275 02DEC2020 20786 Placebo 02DEC2020/ Placebo 28DEC2020/ Placebo 02JUL2021/ BNT162b2 (30 μg)21JUL2021/ BNT162b2 (30 μg) 10091277 C4591001 1009 10091277 03DEC2020 20787 Placebo 03DEC2020/ Placebo 30DEC2020/ Placebo 09JUN2021/ BNT162b2 (30 μg)28JUN2021/ BNT162b2 (30 μg) 10091280 C4591001 1009 10091280 03DEC2020 20789 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10091281 C4591001 1009 10091281 03DEC2020 20791 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10091282 C4591001 1009 10091282 03DEC2020 20914 Placebo 03DEC2020/ Placebo 22DEC2020/ Placebo 21JUN2021/ BNT162b2 (30 μg)12JUL2021/ BNT162b2 (30 μg) 10091283 C4591001 1009 10091283 03DEC2020 20915 Placebo 03DEC2020/ Placebo 23DEC2020/ Placebo 23JUN2021/ BNT162b2 (30 μg)15JUL2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 49 FDA-CBER-2022-5812-0228254 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091284 C4591001 1009 10091284 03DEC2020 20919 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10091287 C4591001 1009 10091287 04DEC2020 20922 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10091288 C4591001 1009 10091288 04DEC2020 21011 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10091289 C4591001 1009 10091289 04DEC2020 21012 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10091292 C4591001 1009 10091292 04DEC2020 21014 Placebo 04DEC2020/ Placebo 23DEC2020/ Placebo 02APR2021/ BNT162b2 (30 μg)23APR2021/ BNT162b2 (30 μg) 10091293 C4591001 1009 10091293 04DEC2020 21015 Placebo 04DEC2020/ Placebo 23DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10091294 C4591001 1009 10091294 07DEC2020 21177 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 06APR2021/ BNT162b2 (30 μg)28APR2021/ BNT162b2 (30 μg) 10091295 C4591001 1009 10091295 07DEC2020 21178 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10091296 C4591001 1009 10091296 07DEC2020 21182 Placebo 07DEC2020/ Placebo 29DEC2020/ Placebo 24JUN2021/ BNT162b2 (30 μg)16JUL2021/ BNT162b2 (30 μg) 10091297 C4591001 1009 10091297 07DEC2020 21188 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 50 FDA-CBER-2022-5812-0228255 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091298 C4591001 1009 10091298 07DEC2020 21300 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10091300 C4591001 1009 10091300 07DEC2020 21302 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10091301 C4591001 1009 10091301 07DEC2020 21303 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 01JUN2021/ BNT162b2 (30 μg)21JUN2021/ BNT162b2 (30 μg) 10091303 C4591001 1009 10091303 08DEC2020 21304 Placebo 08DEC2020/ Placebo 28DEC2020/ Placebo 21JUN2021/ BNT162b2 (30 μg)12JUL2021/ BNT162b2 (30 μg) 10091304 C4591001 1009 10091304 08DEC2020 21537 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10091305 C4591001 1009 10091305 08DEC2020 21543 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 19MAR2021/ BNT162b2 (30 μg)09APR2021/ BNT162b2 (30 μg) 10091306 C4591001 1009 10091306 08DEC2020 21546 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10091307 C4591001 1009 10091307 09DEC2020 21547 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10091308 C4591001 1009 10091308 09DEC2020 21650 Placebo 09DEC2020/ Placebo30DEC2020/ Placebo 10091309 C4591001 1009 10091309 09DEC2020 21652 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10091310 C4591001 1009 10091310 09DEC2020 21653 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 51 FDA-CBER-2022-5812-0228256 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091311 C4591001 1009 10091311 09DEC2020 21655 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10091312 C4591001 1009 10091312 09DEC2020 21782 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 01JUN2021/ BNT162b2 (30 μg)25JUN2021/ BNT162b2 (30 μg) 10091313 C4591001 1009 10091313 09DEC2020 21778 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10091314 C4591001 1009 10091314 09DEC2020 21783 Placebo 09DEC2020/ Placebo 30DEC2020/ Placebo 06JUL2021/ BNT162b2 (30 μg)02AUG2021/ BNT162b2 (30 μg) 10091315 C4591001 1009 10091315 09DEC2020 21785 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10091316 C4591001 1009 10091316 09DEC2020 21813 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 17MAR2021/ BNT162b2 (30 μg)08APR2021/ BNT162b2 (30 μg) 10091317 C4591001 1009 10091317 10DEC2020 21814 Placebo 10DEC2020/ Placebo 29DEC2020/ Placebo 25JUN2021/ BNT162b2 (30 μg)15JUL2021/ BNT162b2 (30 μg) 10091318 C4591001 1009 10091318 10DEC2020 21821 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10091319 C4591001 1009 10091319 10DEC2020 21823 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10091320 C4591001 1009 10091320 10DEC2020 21957 Placebo 10DEC2020/ Placebo 30DEC2020/ Placebo 01JUN2021/ BNT162b2 (30 μg)28JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 52 FDA-CBER-2022-5812-0228257 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091321 C4591001 1009 10091321 10DEC2020 21958 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10091322 C4591001 1009 10091322 10DEC2020 21959 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10091323 C4591001 1009 10091323 10DEC2020 21964 Placebo 10DEC2020/ Placebo 30DEC2020/ Placebo 06JUL2021/ BNT162b2 (30 μg)26JUL2021/ BNT162b2 (30 μg) 10091324 C4591001 1009 10091324 11DEC2020 22066 Placebo 11DEC2020/ Placebo 31DEC2020/ Placebo 29JUL2021/ BNT162b2 (30 μg)18AUG2021/ BNT162b2 (30 μg) 10091325 C4591001 1009 10091325 11DEC2020 22067 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)31DEC2020/ BNT162b2 (30 μg) 10091326 C4591001 1009 10091326 11DEC2020 22072 Placebo 11DEC2020/ Placebo 30DEC2020/ Placebo 27MAY2021/ BNT162b2 (30 μg)25JUN2021/ BNT162b2 (30 μg) 10091328 C4591001 1009 10091328 11DEC2020 22075 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10091329 C4591001 1009 10091329 11DEC2020 22149 Placebo 11DEC2020/ Placebo 30DEC2020/ Placebo 28MAY2021/ BNT162b2 (30 μg)17JUN2021/ BNT162b2 (30 μg) 10091330 C4591001 1009 10091330 11DEC2020 22151 Placebo 11DEC2020/ Placebo 30DEC2020/ Placebo 07JUL2021/ BNT162b2 (30 μg)28JUL2021/ BNT162b2 (30 μg) 10091331 C4591001 1009 10091331 11DEC2020 22157 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 53 FDA-CBER-2022-5812-0228258 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091332 C4591001 1009 10091332 11DEC2020 22160 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10091333 C4591001 1009 10091333 11DEC2020 22198 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10091334 C4591001 1009 10091334 11DEC2020 22199 Placebo 11DEC2020/ Placebo 31DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10091335 C4591001 1009 10091335 11DEC2020 22200 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)31DEC2020/ BNT162b2 (30 μg) 10091336 C4591001 1009 10091336 11DEC2020 22201 Placebo 11DEC2020/ Placebo 31DEC2020/ Placebo 16JUL2021/ BNT162b2 (30 μg)05AUG2021/ BNT162b2 (30 μg) 10091337 C4591001 1009 10091337 14DEC2020 22329 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10091338 C4591001 1009 10091338 14DEC2020 22331 Placebo 14DEC2020/ Placebo 20JUL2021/ BNT162b2 (30 μg)10AUG2021/ BNT162b2 (30 μg) 10091339 C4591001 1009 10091339 14DEC2020 22332 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10091340 C4591001 1009 10091340 14DEC2020 22339 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10091341 C4591001 1009 10091341 14DEC2020 22451 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 02JUL2021/ BNT162b2 (30 μg)21JUL2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 54 FDA-CBER-2022-5812-0228259 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091342 C4591001 1009 10091342 14DEC2020 22452 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10091343 C4591001 1009 10091343 15DEC2020 22454 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10091344 C4591001 1009 10091344 15DEC2020 22458 Placebo 15DEC2020/ Placebo 04JAN2021/ Placebo 01MAR2021/ BNT162b2 (30 μg)23MAR2021/ BNT162b2 (30 μg) 10091345 C4591001 1009 10091345 15DEC2020 22618 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10091346 C4591001 1009 10091346 15DEC2020 22621 Placebo 15DEC2020/ Placebo 05JAN2021/ Placebo 18MAR2021/ BNT162b2 (30 μg)06APR2021/ BNT162b2 (30 μg) 10091347 C4591001 1009 10091347 15DEC2020 22625 Placebo 15DEC2020/ Placebo 06JAN2021/ Placebo 09JUL2021/ BNT162b2 (30 μg)05AUG2021/ BNT162b2 (30 μg) 10091348 C4591001 1009 10091348 15DEC2020 22626 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10091349 C4591001 1009 10091349 15DEC2020 22701 Placebo 15DEC2020/ Placebo 06JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10091350 C4591001 1009 10091350 16DEC2020 22702 Placebo 16DEC2020/ Placebo 07JAN2021/ Placebo 14JUL2021/ BNT162b2 (30 μg)04AUG2021/ BNT162b2 (30 μg) 10091351 C4591001 1009 10091351 16DEC2020 22706 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 55 FDA-CBER-2022-5812-0228260 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091353 C4591001 1009 10091353 16DEC2020 22707 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10091354 C4591001 1009 10091354 16DEC2020 22906 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 10091355 C4591001 1009 10091355 16DEC2020 22907 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10091356 C4591001 1009 10091356 16DEC2020 22909 Placebo 16DEC2020/ Placebo 04JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10091357 C4591001 1009 10091357 17DEC2020 22912 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 16MAR2021/ BNT162b2 (30 μg)05APR2021/ BNT162b2 (30 μg) 10091358 C4591001 1009 10091358 17DEC2020 23001 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10091359 C4591001 1009 10091359 17DEC2020 23002 Placebo 17DEC2020/ Placebo 06JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10091360 C4591001 1009 10091360 17DEC2020 23003 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10091361 C4591001 1009 10091361 17DEC2020 23012 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10091362 C4591001 1009 10091362 17DEC2020 23181 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 56 FDA-CBER-2022-5812-0228261 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091363 C4591001 1009 10091363 17DEC2020 23186 Placebo 17DEC2020/ Placebo 30JUL2021/ BNT162b2 (30 μg)27AUG2021/ BNT162b2 (30 μg) 10091364 C4591001 1009 10091364 17DEC2020 23189 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10091365 C4591001 1009 10091365 17DEC2020 23191 Placebo 17DEC2020/ Placebo 19JAN2021/ Placebo 20JUL2021/ BNT162b2 (30 μg)19AUG2021/ BNT162b2 (30 μg) 10091366 C4591001 1009 10091366 17DEC2020 23213 Placebo 17DEC2020/ Placebo 10AUG2021/ BNT162b2 (30 μg)30AUG2021/ BNT162b2 (30 μg) 10091369 C4591001 1009 10091369 18DEC2020 23214 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10091370 C4591001 1009 10091370 18DEC2020 23215 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10091371 C4591001 1009 10091371 18DEC2020 23216 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10091372 C4591001 1009 10091372 18DEC2020 23435 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10091373 C4591001 1009 10091373 18DEC2020 23441 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 16JUL2021/ BNT162b2 (30 μg)06AUG2021/ BNT162b2 (30 μg) 10091374 C4591001 1009 10091374 21DEC2020 23442 Placebo 21DEC2020/ Placebo 11JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 57 FDA-CBER-2022-5812-0228262 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091375 C4591001 1009 10091375 21DEC2020 23444 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10091376 C4591001 1009 10091376 21DEC2020 23805 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10091377 C4591001 1009 10091377 21DEC2020 23808 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10091378 C4591001 1009 10091378 21DEC2020 23812 Placebo 21DEC2020/ Placebo 12JAN2021/ Placebo 26JUL2021/ BNT162b2 (30 μg)18AUG2021/ BNT162b2 (30 μg) 10091379 C4591001 1009 10091379 22DEC2020 23814 Placebo 22DEC2020/ Placebo 14JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10091380 C4591001 1009 10091380 29DEC2020 24802 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 23JUN2021/ BNT162b2 (30 μg)12JUL2021/ BNT162b2 (30 μg) 10091381 C4591001 1009 10091381 31DEC2020 24806 BNT162b2 (30 μg) 31DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10091382 C4591001 1009 10091382 04JAN2021 24808 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10091383 C4591001 1009 10091383 05JAN2021 24810 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10091384 C4591001 1009 10091384 05JAN2021 25498 Placebo 05JAN2021/ Placebo 25JAN2021/ Placebo 23FEB2021/ BNT162b2 (30 μg)16MAR2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 58 FDA-CBER-2022-5812-0228263 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091385 C4591001 1009 10091385 05JAN2021 25502 Placebo 05JAN2021/ Placebo 26JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10091386 C4591001 1009 10091386 06JAN2021 25505 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10091387 C4591001 1009 10091387 06JAN2021 25506 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10091388 C4591001 1009 10091388 06JAN2021 25872 Placebo 06JAN2021/ Placebo 28JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10091389 C4591001 1009 10091389 06JAN2021 25878 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10091390 C4591001 1009 10091390 07JAN2021 25879 Placebo 07JAN2021/ Placebo 28JAN2021/ Placebo 02AUG2021/ BNT162b2 (30 μg)23AUG2021/ BNT162b2 (30 μg) 10091391 C4591001 1009 10091391 07JAN2021 26073 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10091392 C4591001 1009 10091392 07JAN2021 26075 Placebo 07JAN2021/ Placebo 29JAN2021/ Placebo 01JUL2021/ BNT162b2 (30 μg)22JUL2021/ BNT162b2 (30 μg) 10091393 C4591001 1009 10091393 07JAN2021 25880 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10091394 C4591001 1009 10091394 07JAN2021 26076 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 59 FDA-CBER-2022-5812-0228264 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091395 C4591001 1009 10091395 07JAN2021 26079 Placebo 07JAN2021/ Placebo 27JAN2021/ Placebo 26MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10091396 C4591001 1009 10091396 07JAN2021 26113 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10091398 C4591001 1009 10091398 07JAN2021 26114 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10091399 C4591001 1009 10091399 08JAN2021 26115 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 30JUL2021/ BNT162b2 (30 μg)20AUG2021/ BNT162b2 (30 μg) 10091400 C4591001 1009 10091400 08JAN2021 26119 Placebo 08JAN2021/ Placebo 12FEB2021/ Placebo 30AUG2021/ BNT162b2 (30 μg) 10091401 C4591001 1009 10091401 08JAN2021 26375 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 02AUG2021/ BNT162b2 (30 μg)23AUG2021/ BNT162b2 (30 μg) 10091402 C4591001 1009 10091402 08JAN2021 26377 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10091403 C4591001 1009 10091403 08JAN2021 26378 Placebo 08JAN2021/ Placebo 27JAN2021/ Placebo 24FEB2021/ BNT162b2 (30 μg)19MAR2021/ BNT162b2 (30 μg) 10091404 C4591001 1009 10091404 08JAN2021 26380 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10091405 C4591001 1009 10091405 08JAN2021 26445 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 28JUL2021/ BNT162b2 (30 μg)19AUG2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 60 FDA-CBER-2022-5812-0228265 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10091406 C4591001 1009 10091406 08JAN2021 26447 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 27JUL2021/ BNT162b2 (30 μg)19AUG2021/ BNT162b2 (30 μg) 10091407 C4591001 1009 10091407 11JAN2021 26450 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10091408 C4591001 1009 10091408 11JAN2021 26453 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10091409 C4591001 1009 10091409 11JAN2021 26737 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10091410 C4591001 1009 10091410 12JAN2021 26740 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10091411 C4591001 1009 10091411 12JAN2021 26743 Placebo 12JAN2021/ Placebo 01FEB2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10091412 C4591001 1009 10091412 12JAN2021 26744 Placebo 12JAN2021/ Placebo 01FEB2021/ Placebo 30JUL2021/ BNT162b2 (30 μg)20AUG2021/ BNT162b2 (30 μg) 10091413 C4591001 1009 10091413 12JAN2021 26916 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 10091414 C4591001 1009 10091414 12JAN2021 26920 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)04FEB2021/ BNT162b2 (30 μg) 10131821 C4591001 1013 10131821 30NOV2020 20333 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 61 FDA-CBER-2022-5812-0228266 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10131822 C4591001 1013 10131822 30NOV2020 20332 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10131823 C4591001 1013 10131823 01DEC2020 20335 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 23JUN2021/ BNT162b2 (30 μg)13JUL2021/ BNT162b2 (30 μg) 10131824 C4591001 1013 10131824 01DEC2020 20554 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10131826 C4591001 1013 10131826 01DEC2020 20558 Placebo 01DEC2020/ Placebo 23DEC2020/ Placebo 02JUN2021/ BNT162b2 (30 μg)21JUN2021/ BNT162b2 (30 μg) 10131828 C4591001 1013 10131828 02DEC2020 20559 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10131830 C4591001 1013 10131830 02DEC2020 20564 Placebo 02DEC2020/ Placebo23DEC2020/ Placebo 10131835 C4591001 1013 10131835 02DEC2020 20676 Placebo 02DEC2020/ Placebo 22DEC2020/ Placebo 26MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10131836 C4591001 1013 10131836 02DEC2020 20681 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10131839 C4591001 1013 10131839 02DEC2020 20682 Placebo 02DEC2020/ Placebo23DEC2020/ Placebo 10131841 C4591001 1013 10131841 02DEC2020 20736 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10131842 C4591001 1013 10131842 02DEC2020 20738 Placebo 02DEC2020/ Placebo 22DEC2020/ Placebo 17JUN2021/ BNT162b2 (30 μg)20JUL2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 62 FDA-CBER-2022-5812-0228267 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10131843 C4591001 1013 10131843 02DEC2020 20684 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10131844 C4591001 1013 10131844 02DEC2020 20743 Placebo 02DEC2020/ Placebo 22DEC2020/ Placebo 24JUN2021/ BNT162b2 (30 μg)15JUL2021/ BNT162b2 (30 μg) 10131845 C4591001 1013 10131845 03DEC2020 20744 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10131846 C4591001 1013 10131846 03DEC2020 20821 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10131848 C4591001 1013 10131848 03DEC2020 20825 Placebo 03DEC2020/ Placebo22DEC2020/ Placebo 10131850 C4591001 1013 10131850 03DEC2020 20827 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10131851 C4591001 1013 10131851 07DEC2020 20828 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 21JUN2021/ BNT162b2 (30 μg)26JUL2021/ BNT162b2 (30 μg) 10131852 C4591001 1013 10131852 07DEC2020 21153 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 01JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10131855 C4591001 1013 10131855 08DEC2020 21154 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10131856 C4591001 1013 10131856 09DEC2020 21671 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10131858 C4591001 1013 10131858 09DEC2020 21164 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 63 FDA-CBER-2022-5812-0228268 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10131859 C4591001 1013 10131859 09DEC2020 21155 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)31DEC2020/ BNT162b2 (30 μg) 10131860 C4591001 1013 10131860 09DEC2020 21673 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 26MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10131861 C4591001 1013 10131861 10DEC2020 21677 Placebo 10DEC2020/ Placebo04JAN2021/ Placebo 10131862 C4591001 1013 10131862 10DEC2020 21678 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10131863 C4591001 1013 10131863 10DEC2020 21983 Placebo 10DEC2020/ Placebo 30DEC2020/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10131865 C4591001 1013 10131865 14DEC2020 21987 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10131866 C4591001 1013 10131866 14DEC2020 21990 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10131867 C4591001 1013 10131867 17DEC2020 21992 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 01JUN2021/ BNT162b2 (30 μg)30JUN2021/ BNT162b2 (30 μg) 10131868 C4591001 1013 10131868 21DEC2020 23579 Placebo 21DEC2020/ Placebo12JAN2021/ Placebo 10131869 C4591001 1013 10131869 21DEC2020 117929 Placebo 21DEC2020/ Placebo13JAN2021/ Placebo 10131870 C4591001 1013 10131870 21DEC2020 23583 Placebo 21DEC2020/ Placebo13JAN2021/ Placebo 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 64 FDA-CBER-2022-5812-0228269 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10131871 C4591001 1013 10131871 21DEC2020 23585 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10131872 C4591001 1013 10131872 21DEC2020 23586 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10131873 C4591001 1013 10131873 22DEC2020 24005 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10131874 C4591001 1013 10131874 22DEC2020 24002 Placebo 22DEC2020/ Placebo 13JAN2021/ Placebo 20JUL2021/ BNT162b2 (30 μg)11AUG2021/ BNT162b2 (30 μg) 10131875 C4591001 1013 10131875 22DEC2020 24004 Placebo 22DEC2020/ Placebo 13JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10131876 C4591001 1013 10131876 22DEC2020 24008 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)12JAN2021/ BNT162b2 (30 μg) 10131877 C4591001 1013 10131877 23DEC2020 24167 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10131878 C4591001 1013 10131878 23DEC2020 24174 Placebo 23DEC2020/ Placebo13JAN2021/ Placebo 10131879 C4591001 1013 10131879 23DEC2020 24168 Placebo 23DEC2020/ Placebo 11JAN2021/ Placebo 28APR2021/ BNT162b2 (30 μg)19MAY2021/ BNT162b2 (30 μg) 10131880 C4591001 1013 10131880 23DEC2020 24173 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10131881 C4591001 1013 10131881 28DEC2020 24361 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 65 FDA-CBER-2022-5812-0228270 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10131882 C4591001 1013 10131882 30DEC2020 24365 Placebo 30DEC2020/ Placebo 19JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10131883 C4591001 1013 10131883 31DEC2020 24366 Placebo 31DEC2020/ Placebo 21JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10131884 C4591001 1013 10131884 07JAN2021 24368 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10131885 C4591001 1013 10131885 07JAN2021 25893 Placebo 07JAN2021/ Placebo 26JAN2021/ Placebo 27MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10131886 C4591001 1013 10131886 07JAN2021 25894 Placebo 07JAN2021/ Placebo 27JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10161307 C4591001 1016 10161307 15OCT2020 20025 Placebo 15OCT2020/ Placebo 04NOV2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10161308 C4591001 1016 10161308 15OCT2020 20032 Placebo 15OCT2020/ Placebo 03NOV2020/ Placebo 26MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10161309 C4591001 1016 10161309 15OCT2020 20035 BNT162b2 (30 μg) 15OCT2020/ BNT162b2 (30 μg)12NOV2020/ BNT162b2 (30 μg) 10161310 C4591001 1016 10161310 15OCT2020 20036 BNT162b2 (30 μg) 15OCT2020/ BNT162b2 (30 μg)04NOV2020/ BNT162b2 (30 μg) 10161311 C4591001 1016 10161311 15OCT2020 20052 BNT162b2 (30 μg) 15OCT2020/ BNT162b2 (30 μg)03NOV2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 66 FDA-CBER-2022-5812-0228271 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10161314 C4591001 1016 10161314 16OCT2020 20053 BNT162b2 (30 μg) 16OCT2020/ BNT162b2 (30 μg)05NOV2020/ BNT162b2 (30 μg) 10161315 C4591001 1016 10161315 16OCT2020 20055 Placebo 16OCT2020/ Placebo 06NOV2020/ Placebo 20MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10161316 C4591001 1016 10161316 16OCT2020 20058 Placebo 16OCT2020/ Placebo 25FEB2021/ BNT162b2 (30 μg)16MAR2021/ BNT162b2 (30 μg) 10161318 C4591001 1016 10161318 16OCT2020 20099 Placebo 16OCT2020/ Placebo 04NOV2020/ Placebo 10JUN2021/ BNT162b2 (30 μg)29JUN2021/ BNT162b2 (30 μg) 10161319 C4591001 1016 10161319 16OCT2020 20103 Placebo 16OCT2020/ Placebo 04NOV2020/ Placebo 25MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10161320 C4591001 1016 10161320 21OCT2020 20176 BNT162b2 (30 μg) 21OCT2020/ BNT162b2 (30 μg)09NOV2020/ BNT162b2 (30 μg) 10161322 C4591001 1016 10161322 19OCT2020 20107 BNT162b2 (30 μg) 19OCT2020/ BNT162b2 (30 μg)09NOV2020/ BNT162b2 (30 μg) 10161323 C4591001 1016 10161323 19OCT2020 20108 BNT162b2 (30 μg) 19OCT2020/ BNT162b2 (30 μg)09NOV2020/ BNT162b2 (30 μg) 10161324 C4591001 1016 10161324 19OCT2020 20109 Placebo 19OCT2020/ Placebo 09NOV2020/ Placebo 27MAY2021/ BNT162b2 (30 μg)17JUN2021/ BNT162b2 (30 μg) 10161325 C4591001 1016 10161325 19OCT2020 20110 BNT162b2 (30 μg) 19OCT2020/ BNT162b2 (30 μg)10NOV2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 67 FDA-CBER-2022-5812-0228272 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10161326 C4591001 1016 10161326 20OCT2020 20114 BNT162b2 (30 μg) 20OCT2020/ BNT162b2 (30 μg)10NOV2020/ BNT162b2 (30 μg) 10161327 C4591001 1016 10161327 20OCT2020 20120 Placebo 20OCT2020/ Placebo 10NOV2020/ Placebo 01JUN2021/ BNT162b2 (30 μg)22JUN2021/ BNT162b2 (30 μg) 10161329 C4591001 1016 10161329 20OCT2020 20171 Placebo 20OCT2020/ Placebo 10NOV2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10161330 C4591001 1016 10161330 20OCT2020 20174 BNT162b2 (30 μg) 20OCT2020/ BNT162b2 (30 μg)11NOV2020/ BNT162b2 (30 μg) 10161331 C4591001 1016 10161331 20OCT2020 20172 Placebo 20OCT2020/ Placebo 11NOV2020/ Placebo 26MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10161332 C4591001 1016 10161332 21OCT2020 20229 BNT162b2 (30 μg) 21OCT2020/ BNT162b2 (30 μg)09NOV2020/ BNT162b2 (30 μg) 10161334 C4591001 1016 10161334 21OCT2020 20231 Placebo 21OCT2020/ Placebo 11NOV2020/ Placebo 27MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10161335 C4591001 1016 10161335 21OCT2020 20240 BNT162b2 (30 μg) 21OCT2020/ BNT162b2 (30 μg)11NOV2020/ BNT162b2 (30 μg) 10161336 C4591001 1016 10161336 21OCT2020 20258 Placebo 21OCT2020/ Placebo 11NOV2020/ Placebo 06JUL2021/ BNT162b2 (30 μg)26JUL2021/ BNT162b2 (30 μg) 10161337 C4591001 1016 10161337 21OCT2020 20236 Placebo 21OCT2020/ Placebo 10NOV2020/ Placebo 19APR2021/ BNT162b2 (30 μg)10MAY2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 68 FDA-CBER-2022-5812-0228273 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10161338 C4591001 1016 10161338 22OCT2020 20259 BNT162b2 (30 μg) 22OCT2020/ BNT162b2 (30 μg)10NOV2020/ BNT162b2 (30 μg) 10161339 C4591001 1016 10161339 22OCT2020 20262 BNT162b2 (30 μg) 22OCT2020/ BNT162b2 (30 μg)10NOV2020/ BNT162b2 (30 μg) 10161340 C4591001 1016 10161340 22OCT2020 20263 Placebo 22OCT2020/ Placebo 10NOV2020/ Placebo 26MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10161343 C4591001 1016 10161343 22OCT2020 20301 BNT162b2 (30 μg) 22OCT2020/ BNT162b2 (30 μg)13NOV2020/ BNT162b2 (30 μg) 10161344 C4591001 1016 10161344 22OCT2020 20306 Placebo 22OCT2020/ Placebo 11NOV2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10161350 C4591001 1016 10161350 30NOV2020 20309 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10161351 C4591001 1016 10161351 30NOV2020 20308 Placebo 30NOV2020/ Placebo 21DEC2020/ Placebo 14JUN2021/ BNT162b2 (30 μg)12JUL2021/ BNT162b2 (30 μg) 10161352 C4591001 1016 10161352 30NOV2020 20410 Placebo 30NOV2020/ Placebo 21DEC2020/ Placebo 01JUN2021/ BNT162b2 (30 μg)21JUN2021/ BNT162b2 (30 μg) 10161353 C4591001 1016 10161353 30NOV2020 20411 Placebo 30NOV2020/ Placebo 23DEC2020/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10161354 C4591001 1016 10161354 02DEC2020 20412 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 69 FDA-CBER-2022-5812-0228274 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10161356 C4591001 1016 10161356 02DEC2020 20416 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10161357 C4591001 1016 10161357 02DEC2020 20653 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10161358 C4591001 1016 10161358 03DEC2020 20657 Placebo 03DEC2020/ Placebo22DEC2020/ Placebo 10161361 C4591001 1016 10161361 04DEC2020 20658 Placebo 04DEC2020/ Placebo 23DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10161362 C4591001 1016 10161362 04DEC2020 20659 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10161363 C4591001 1016 10161363 08DEC2020 21477 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10161364 C4591001 1016 10161364 09DEC2020 21478 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)31DEC2020/ BNT162b2 (30 μg) 10161365 C4591001 1016 10161365 10DEC2020 21481 Placebo 10DEC2020/ Placebo 29DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10161366 C4591001 1016 10161366 15DEC2020 21488 Placebo 15DEC2020/ Placebo 07JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUL2021/ BNT162b2 (30 μg) 10161367 C4591001 1016 10161367 29DEC2020 24585 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10161368 C4591001 1016 10161368 30DEC2020 24589 Placebo 30DEC2020/ Placebo 19JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 70 FDA-CBER-2022-5812-0228275 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10161369 C4591001 1016 10161369 30DEC2020 24594 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10161370 C4591001 1016 10161370 04JAN2021 24595 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10161371 C4591001 1016 10161371 04JAN2021 25234 Placebo 04JAN2021/ Placebo 26JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10161372 C4591001 1016 10161372 05JAN2021 25237 Placebo 05JAN2021/ Placebo 27JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10161373 C4591001 1016 10161373 05JAN2021 25238 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10161374 C4591001 1016 10161374 06JAN2021 25244 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10161375 C4591001 1016 10161375 06JAN2021 25790 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10161376 C4591001 1016 10161376 07JAN2021 25795 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10161377 C4591001 1016 10161377 07JAN2021 25793 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10161378 C4591001 1016 10161378 07JAN2021 25796 Placebo 07JAN2021/ Placebo 26JAN2021/ Placebo 04AUG2021/ BNT162b2 (30 μg)25AUG2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 71 FDA-CBER-2022-5812-0228276 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10161379 C4591001 1016 10161379 07JAN2021 26104 Placebo 07JAN2021/ Placebo 01JUN2021/ BNT162b2 (30 μg)28JUN2021/ BNT162b2 (30 μg) 10161381 C4591001 1016 10161381 08JAN2021 26105 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10161382 C4591001 1016 10161382 08JAN2021 26106 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10161383 C4591001 1016 10161383 08JAN2021 26107 Placebo 08JAN2021/ Placebo 28JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)01JUN2021/ BNT162b2 (30 μg) 10161384 C4591001 1016 10161384 08JAN2021 26170 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10161385 C4591001 1016 10161385 08JAN2021 26172 Placebo 08JAN2021/ Placebo29JAN2021/ Placebo 10161386 C4591001 1016 10161386 08JAN2021 26179 Placebo 08JAN2021/ Placebo 28JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)01JUN2021/ BNT162b2 (30 μg) 10161387 C4591001 1016 10161387 08JAN2021 26180 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10161388 C4591001 1016 10161388 11JAN2021 26698 Placebo 11JAN2021/ Placebo 02FEB2021/ Placebo 05MAY2021/ BNT162b2 (30 μg)24MAY2021/ BNT162b2 (30 μg) 10391246 C4591001 1039 10391246 01DEC2020 20459 Placebo 01DEC2020/ Placebo 21DEC2020/ Placebo 26FEB2021/ BNT162b2 (30 μg)18MAR2021/ BNT162b2 (30 μg) 10391247 C4591001 1039 10391247 01DEC2020 20460 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 72 FDA-CBER-2022-5812-0228277 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10391250 C4591001 1039 10391250 04DEC2020 20465 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10391251 C4591001 1039 10391251 07DEC2020 20467 Placebo 07DEC2020/ Placebo 04JAN2021/ Placebo 02FEB2021/ BNT162b2 (30 μg)25FEB2021/ BNT162b2 (30 μg) 10391252 C4591001 1039 10391252 07DEC2020 21109 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 25MAR2021/ BNT162b2 (30 μg)15APR2021/ BNT162b2 (30 μg) 10391253 C4591001 1039 10391253 07DEC2020 21111 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10391255 C4591001 1039 10391255 07DEC2020 21112 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10391256 C4591001 1039 10391256 07DEC2020 21201 Placebo 07DEC2020/ Placebo 29DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10391258 C4591001 1039 10391258 07DEC2020 21113 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)01JUN2021/ BNT162b2 (30 μg) 10391259 C4591001 1039 10391259 07DEC2020 21202 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391260 C4591001 1039 10391260 07DEC2020 21209 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10391262 C4591001 1039 10391262 08DEC2020 21212 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 73 FDA-CBER-2022-5812-0228278 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10391263 C4591001 1039 10391263 08DEC2020 21357 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10391264 C4591001 1039 10391264 08DEC2020 21361 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 24MAY2021/ BNT162b2 (30 μg) 10391265 C4591001 1039 10391265 08DEC2020 21364 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10391266 C4591001 1039 10391266 08DEC2020 21368 Placebo 08DEC2020/ Placebo 29DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10391267 C4591001 1039 10391267 08DEC2020 21434 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10391268 C4591001 1039 10391268 08DEC2020 21430 Placebo 08DEC2020/ Placebo 28DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391269 C4591001 1039 10391269 08DEC2020 21431 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10391270 C4591001 1039 10391270 09DEC2020 21437 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10391271 C4591001 1039 10391271 09DEC2020 21721 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10391272 C4591001 1039 10391272 09DEC2020 21723 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 74 FDA-CBER-2022-5812-0228279 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10391273 C4591001 1039 10391273 09DEC2020 21717 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10391274 C4591001 1039 10391274 16DEC2020 22739 Placebo 16DEC2020/ Placebo 04JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391275 C4591001 1039 10391275 16DEC2020 21727 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10391276 C4591001 1039 10391276 16DEC2020 22740 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10391277 C4591001 1039 10391277 16DEC2020 22742 Placebo 16DEC2020/ Placebo 06JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391278 C4591001 1039 10391278 16DEC2020 22747 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10391279 C4591001 1039 10391279 16DEC2020 22813 Placebo 16DEC2020/ Placebo 06JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10391280 C4591001 1039 10391280 17DEC2020 22814 Placebo 17DEC2020/ Placebo 07JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391281 C4591001 1039 10391281 17DEC2020 22816 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10391282 C4591001 1039 10391282 18DEC2020 22818 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 75 FDA-CBER-2022-5812-0228280 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10391283 C4591001 1039 10391283 18DEC2020 23270 Placebo 18DEC2020/ Placebo 07JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10391284 C4591001 1039 10391284 18DEC2020 23272 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 10391285 C4591001 1039 10391285 18DEC2020 23275 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391286 C4591001 1039 10391286 18DEC2020 23276 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10391287 C4591001 1039 10391287 18DEC2020 23326 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10391289 C4591001 1039 10391289 18DEC2020 23327 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10391290 C4591001 1039 10391290 18DEC2020 23328 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10391291 C4591001 1039 10391291 18DEC2020 23373 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 26MAR2021/ BNT162b2 (30 μg)16APR2021/ BNT162b2 (30 μg) 10391292 C4591001 1039 10391292 18DEC2020 23332 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391293 C4591001 1039 10391293 21DEC2020 23378 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 76 FDA-CBER-2022-5812-0228281 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10391294 C4591001 1039 10391294 21DEC2020 23381 Placebo 21DEC2020/ Placebo 13JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391295 C4591001 1039 10391295 29DEC2020 23384 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10391296 C4591001 1039 10391296 29DEC2020 24563 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391297 C4591001 1039 10391297 29DEC2020 24564 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10391298 C4591001 1039 10391298 29DEC2020 24565 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10391299 C4591001 1039 10391299 29DEC2020 24568 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391300 C4591001 1039 10391300 29DEC2020 24664 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10391301 C4591001 1039 10391301 29DEC2020 24665 Placebo 29DEC2020/ Placebo 21JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391302 C4591001 1039 10391302 29DEC2020 24666 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10391303 C4591001 1039 10391303 29DEC2020 24667 Placebo 29DEC2020/ Placebo 21JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 77 FDA-CBER-2022-5812-0228282 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10391304 C4591001 1039 10391304 29DEC2020 24754 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 10391305 C4591001 1039 10391305 06JAN2021 24759 Placebo 06JAN2021/ Placebo 25JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391306 C4591001 1039 10391306 06JAN2021 24762 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10391307 C4591001 1039 10391307 06JAN2021 24764 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391308 C4591001 1039 10391308 06JAN2021 25749 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10391309 C4591001 1039 10391309 07JAN2021 25752 Placebo 07JAN2021/ Placebo 27JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10391310 C4591001 1039 10391310 07JAN2021 25759 Placebo 07JAN2021/ Placebo 26JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10391311 C4591001 1039 10391311 07JAN2021 25918 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10391312 C4591001 1039 10391312 07JAN2021 25760 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10391313 C4591001 1039 10391313 07JAN2021 25920 Placebo 07JAN2021/ Placebo 28JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 78 FDA-CBER-2022-5812-0228283 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10391314 C4591001 1039 10391314 07JAN2021 25921 Placebo 07JAN2021/ Placebo 28JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10391315 C4591001 1039 10391315 07JAN2021 25924 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10391316 C4591001 1039 10391316 07JAN2021 26039 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10391317 C4591001 1039 10391317 07JAN2021 26040 Placebo 07JAN2021/ Placebo 28JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10391318 C4591001 1039 10391318 07JAN2021 26041 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10391319 C4591001 1039 10391319 08JAN2021 26042 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10391320 C4591001 1039 10391320 08JAN2021 26184 Placebo 08JAN2021/ Placebo29JAN2021/ Placebo 10391321 C4591001 1039 10391321 08JAN2021 26182 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10391322 C4591001 1039 10391322 08JAN2021 26187 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10391323 C4591001 1039 10391323 08JAN2021 26191 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10391324 C4591001 1039 10391324 08JAN2021 26398 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 79 FDA-CBER-2022-5812-0228284 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10391325 C4591001 1039 10391325 11JAN2021 26403 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10391326 C4591001 1039 10391326 11JAN2021 26405 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10391327 C4591001 1039 10391327 11JAN2021 26408 Placebo 11JAN2021/ Placebo01FEB2021/ Placebo 10391328 C4591001 1039 10391328 11JAN2021 26639 Placebo 11JAN2021/ Placebo 02FEB2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391329 C4591001 1039 10391329 11JAN2021 26644 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)10JUN2021/ BNT162b2 (30 μg) 10391330 C4591001 1039 10391330 11JAN2021 26640 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10391331 C4591001 1039 10391331 12JAN2021 26648 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10391332 C4591001 1039 10391332 12JAN2021 26769 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10391333 C4591001 1039 10391333 12JAN2021 26770 Placebo 12JAN2021/ Placebo 02FEB2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10391334 C4591001 1039 10391334 12JAN2021 26772 Placebo 12JAN2021/ Placebo 02FEB2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10391335 C4591001 1039 10391335 12JAN2021 26817 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 80 FDA-CBER-2022-5812-0228285 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10391336 C4591001 1039 10391336 12JAN2021 26780 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10391337 C4591001 1039 10391337 12JAN2021 26822 Placebo 12JAN2021/ Placebo 03FEB2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10391338 C4591001 1039 10391338 12JAN2021 26823 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 10391339 C4591001 1039 10391339 12JAN2021 26828 Placebo 12JAN2021/ Placebo 03FEB2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10441251 C4591001 1044 10441251 30NOV2020 20354 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10441252 C4591001 1044 10441252 30NOV2020 20360 Placebo 30NOV2020/ Placebo 21DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10441253 C4591001 1044 10441253 30NOV2020 20439 BNT162b2 (30 μg) 30NOV2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10441255 C4591001 1044 10441255 01DEC2020 20440 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10441256 C4591001 1044 10441256 01DEC2020 20444 Placebo 01DEC2020/ Placebo 21DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10441257 C4591001 1044 10441257 01DEC2020 20567 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 81 FDA-CBER-2022-5812-0228286 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441259 C4591001 1044 10441259 01DEC2020 20569 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10441260 C4591001 1044 10441260 01DEC2020 20576 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10441261 C4591001 1044 10441261 01DEC2020 20618 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10441263 C4591001 1044 10441263 07DEC2020 20623 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10441264 C4591001 1044 10441264 07DEC2020 20624 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 26JUL2021/ BNT162b2 (30 μg)23AUG2021/ BNT162b2 (30 μg) 10441265 C4591001 1044 10441265 07DEC2020 21287 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10441266 C4591001 1044 10441266 08DEC2020 21289 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10441267 C4591001 1044 10441267 08DEC2020 21290 Placebo 08DEC2020/ Placebo 28DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10441268 C4591001 1044 10441268 08DEC2020 21294 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10441270 C4591001 1044 10441270 08DEC2020 21417 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)31DEC2020/ BNT162b2 (30 μg) 10441271 C4591001 1044 10441271 08DEC2020 21420 Placebo 08DEC2020/ Placebo28DEC2020/ Placebo 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 82 FDA-CBER-2022-5812-0228287 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441273 C4591001 1044 10441273 08DEC2020 21423 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10441274 C4591001 1044 10441274 08DEC2020 21428 Placebo 08DEC2020/ Placebo 28DEC2020/ Placebo 17FEB2021/ BNT162b2 (30 μg)12MAR2021/ BNT162b2 (30 μg) 10441275 C4591001 1044 10441275 09DEC2020 21621 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10441276 C4591001 1044 10441276 09DEC2020 21623 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10441277 C4591001 1044 10441277 09DEC2020 21632 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10441278 C4591001 1044 10441278 09DEC2020 21631 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10441279 C4591001 1044 10441279 09DEC2020 21789 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10441280 C4591001 1044 10441280 09DEC2020 21792 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 28JAN2021/ BNT162b2 (30 μg)17FEB2021/ BNT162b2 (30 μg) 10441281 C4591001 1044 10441281 09DEC2020 21795 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10441282 C4591001 1044 10441282 09DEC2020 21799 Placebo 09DEC2020/ Placebo 30DEC2020/ Placebo 03MAR2021/ BNT162b2 (30 μg)24MAR2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 83 FDA-CBER-2022-5812-0228288 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441283 C4591001 1044 10441283 10DEC2020 21840 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10441284 C4591001 1044 10441284 10DEC2020 21843 Placebo 10DEC2020/ Placebo 29DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10441285 C4591001 1044 10441285 10DEC2020 21845 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10441286 C4591001 1044 10441286 11DEC2020 21848 Placebo 11DEC2020/ Placebo 30DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10441288 C4591001 1044 10441288 16DEC2020 22749 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10441289 C4591001 1044 10441289 16DEC2020 22751 Placebo 16DEC2020/ Placebo11JAN2021/ Placebo 10441290 C4591001 1044 10441290 08JAN2021 26233 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10441291 C4591001 1044 10441291 17DEC2020 22752 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10441292 C4591001 1044 10441292 17DEC2020 22759 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 10MAR2021/ BNT162b2 (30 μg)01APR2021/ BNT162b2 (30 μg) 10441293 C4591001 1044 10441293 17DEC2020 23195 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg) 10441294 C4591001 1044 10441294 17DEC2020 23196 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 84 FDA-CBER-2022-5812-0228289 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441295 C4591001 1044 10441295 18DEC2020 23198 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)08JAN2021/ BNT162b2 (30 μg) 10441296 C4591001 1044 10441296 22DEC2020 23202 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10441297 C4591001 1044 10441297 23DEC2020 24157 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10441298 C4591001 1044 10441298 23DEC2020 24160 Placebo 23DEC2020/ Placebo 13JAN2021/ Placebo 28MAY2021/ BNT162b2 (30 μg)18JUN2021/ BNT162b2 (30 μg) 10441299 C4591001 1044 10441299 28DEC2020 24161 Placebo 28DEC2020/ Placebo 19JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10441300 C4591001 1044 10441300 28DEC2020 24163 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10441301 C4591001 1044 10441301 29DEC2020 24721 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10441302 C4591001 1044 10441302 29DEC2020 24723 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10441303 C4591001 1044 10441303 29DEC2020 24722 Placebo 29DEC2020/ Placebo 19JAN2021/ Placebo 20APR2021/ BNT162b2 (30 μg)13MAY2021/ BNT162b2 (30 μg) 10441304 C4591001 1044 10441304 29DEC2020 24728 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)19JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 85 FDA-CBER-2022-5812-0228290 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441306 C4591001 1044 10441306 30DEC2020 24861 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10441307 C4591001 1044 10441307 30DEC2020 24863 Placebo 30DEC2020/ Placebo 18JAN2021/ Placebo 17AUG2021/ BNT162b2 (30 μg) 10441308 C4591001 1044 10441308 30DEC2020 24869 Placebo 30DEC2020/ Placebo 20JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10441309 C4591001 1044 10441309 30DEC2020 24871 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10441310 C4591001 1044 10441310 30DEC2020 24958 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10441311 C4591001 1044 10441311 04JAN2021 24959 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10441312 C4591001 1044 10441312 04JAN2021 24966 Placebo 04JAN2021/ Placebo 26JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10441313 C4591001 1044 10441313 04JAN2021 24968 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 26JUL2021/ BNT162b2 (30 μg)17AUG2021/ BNT162b2 (30 μg) 10441314 C4591001 1044 10441314 04JAN2021 25210 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10441315 C4591001 1044 10441315 04JAN2021 25212 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 86 FDA-CBER-2022-5812-0228291 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441316 C4591001 1044 10441316 04JAN2021 25213 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10441317 C4591001 1044 10441317 04JAN2021 25214 Placebo 04JAN2021/ Placebo 27JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10441318 C4591001 1044 10441318 05JAN2021 25392 Placebo 05JAN2021/ Placebo 25JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10441319 C4591001 1044 10441319 05JAN2021 25394 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10441320 C4591001 1044 10441320 05JAN2021 25395 Placebo 05JAN2021/ Placebo 26JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10441321 C4591001 1044 10441321 05JAN2021 25396 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10441322 C4591001 1044 10441322 05JAN2021 25521 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10441323 C4591001 1044 10441323 05JAN2021 25525 Placebo 05JAN2021/ Placebo 28JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10441324 C4591001 1044 10441324 05JAN2021 25529 Placebo 05JAN2021/ Placebo 25JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10441325 C4591001 1044 10441325 05JAN2021 25531 BNT162b2 (30 μg) 05JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 87 FDA-CBER-2022-5812-0228292 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441326 C4591001 1044 10441326 06JAN2021 25645 Placebo 06JAN2021/ Placebo 25JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10441327 C4591001 1044 10441327 06JAN2021 25647 Placebo 06JAN2021/ Placebo 25JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10441328 C4591001 1044 10441328 06JAN2021 25648 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10441329 C4591001 1044 10441329 06JAN2021 25652 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10441330 C4591001 1044 10441330 06JAN2021 25778 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10441331 C4591001 1044 10441331 06JAN2021 25780 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10441332 C4591001 1044 10441332 06JAN2021 25782 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10441333 C4591001 1044 10441333 06JAN2021 25783 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10441334 C4591001 1044 10441334 07JAN2021 25905 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10441335 C4591001 1044 10441335 07JAN2021 25910 Placebo 07JAN2021/ Placebo 29JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 88 FDA-CBER-2022-5812-0228293 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441336 C4591001 1044 10441336 07JAN2021 25913 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10441337 C4591001 1044 10441337 08JAN2021 25916 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10441338 C4591001 1044 10441338 08JAN2021 26229 Placebo 08JAN2021/ Placebo29JAN2021/ Placebo 10441339 C4591001 1044 10441339 08JAN2021 26234 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10441340 C4591001 1044 10441340 08JAN2021 26326 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)01JUN2021/ BNT162b2 (30 μg) 10441341 C4591001 1044 10441341 08JAN2021 26235 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)01JUN2021/ BNT162b2 (30 μg) 10441342 C4591001 1044 10441342 09JAN2021 26334 BNT162b2 (30 μg) 09JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10441343 C4591001 1044 10441343 09JAN2021 26335 BNT162b2 (30 μg) 09JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10441344 C4591001 1044 10441344 09JAN2021 26336 Placebo 09JAN2021/ Placebo 29JAN2021/ Placebo 19FEB2021/ BNT162b2 (30 μg)16MAR2021/ BNT162b2 (30 μg) 10441345 C4591001 1044 10441345 09JAN2021 26477 Placebo 09JAN2021/ Placebo 28JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10441346 C4591001 1044 10441346 09JAN2021 26470 BNT162b2 (30 μg) 09JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 89 FDA-CBER-2022-5812-0228294 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441347 C4591001 1044 10441347 09JAN2021 26478 Placebo 09JAN2021/ Placebo29JAN2021/ Placebo 10441348 C4591001 1044 10441348 09JAN2021 26494 Placebo 09JAN2021/ Placebo 28JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10441349 C4591001 1044 10441349 09JAN2021 26479 BNT162b2 (30 μg) 09JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10441350 C4591001 1044 10441350 09JAN2021 26500 BNT162b2 (30 μg) 09JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10441351 C4591001 1044 10441351 10JAN2021 26502 Placebo 10JAN2021/ Placebo 01FEB2021/ Placebo 03AUG2021/ BNT162b2 (30 μg)23AUG2021/ BNT162b2 (30 μg) 10441352 C4591001 1044 10441352 10JAN2021 26504 BNT162b2 (30 μg) 10JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10441353 C4591001 1044 10441353 10JAN2021 26508 BNT162b2 (30 μg) 10JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10441354 C4591001 1044 10441354 10JAN2021 26509 Placebo 10JAN2021/ Placebo 29JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10441355 C4591001 1044 10441355 10JAN2021 26513 BNT162b2 (30 μg) 10JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10441356 C4591001 1044 10441356 10JAN2021 26514 Placebo 10JAN2021/ Placebo02FEB2021/ Placebo 10441357 C4591001 1044 10441357 10JAN2021 26521 Placebo 10JAN2021/ Placebo 29JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 90 FDA-CBER-2022-5812-0228295 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441358 C4591001 1044 10441358 10JAN2021 26522 BNT162b2 (30 μg) 10JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10441359 C4591001 1044 10441359 11JAN2021 26528 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)25FEB2021/ BNT162b2 (30 μg) 10441360 C4591001 1044 10441360 11JAN2021 26524 Placebo 11JAN2021/ Placebo 25FEB2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10441361 C4591001 1044 10441361 11JAN2021 26589 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 10441362 C4591001 1044 10441362 11JAN2021 26593 Placebo 11JAN2021/ Placebo 03FEB2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10441363 C4591001 1044 10441363 11JAN2021 26595 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10441364 C4591001 1044 10441364 11JAN2021 26596 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 10441365 C4591001 1044 10441365 11JAN2021 26675 Placebo 11JAN2021/ Placebo 02FEB2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10441366 C4591001 1044 10441366 11JAN2021 26676 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10441367 C4591001 1044 10441367 11JAN2021 26677 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 91 FDA-CBER-2022-5812-0228296 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441368 C4591001 1044 10441368 11JAN2021 26678 Placebo 11JAN2021/ Placebo 03FEB2021/ Placebo 09MAR2021/ BNT162b2 (30 μg)30MAR2021/ BNT162b2 (30 μg) 10441369 C4591001 1044 10441369 11JAN2021 26725 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10441370 C4591001 1044 10441370 11JAN2021 26729 Placebo 11JAN2021/ Placebo 02FEB2021/ Placebo 01JUN2021/ BNT162b2 (30 μg)21JUN2021/ BNT162b2 (30 μg) 10441371 C4591001 1044 10441371 11JAN2021 26730 Placebo 11JAN2021/ Placebo02FEB2021/ Placebo 10441372 C4591001 1044 10441372 11JAN2021 26731 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10441373 C4591001 1044 10441373 12JAN2021 26782 Placebo 12JAN2021/ Placebo 04FEB2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10441374 C4591001 1044 10441374 12JAN2021 26784 Placebo 12JAN2021/ Placebo 02FEB2021/ Placebo 20AUG2021/ BNT162b2 (30 μg) 10441375 C4591001 1044 10441375 12JAN2021 26786 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10441376 C4591001 1044 10441376 12JAN2021 26792 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10441377 C4591001 1044 10441377 12JAN2021 26911 BNT162b2 (30 μg) 01FEB2021/ BNT162b2 (30 μg)22FEB2021/ BNT162b2 (30 μg) 10441378 C4591001 1044 10441378 12JAN2021 26843 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)04FEB2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 92 FDA-CBER-2022-5812-0228297 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10441379 C4591001 1044 10441379 12JAN2021 26845 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)04FEB2021/ BNT162b2 (30 μg) 10441380 C4591001 1044 10441380 12JAN2021 26849 Placebo 12JAN2021/ Placebo 03FEB2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10441381 C4591001 1044 10441381 12JAN2021 26851 Placebo 12JAN2021/ Placebo 01FEB2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10441382 C4591001 1044 10441382 12JAN2021 26901 Placebo 12JAN2021/ Placebo 03FEB2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)02JUN2021/ BNT162b2 (30 μg) 10441383 C4591001 1044 10441383 12JAN2021 26902 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 10441384 C4591001 1044 10441384 12JAN2021 26912 Placebo 12JAN2021/ Placebo 04FEB2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10571376 C4591001 1057 10571376 07DEC2020 21117 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10571377 C4591001 1057 10571377 07DEC2020 21119 Placebo 07DEC2020/ Placebo28DEC2020/ Placebo 10571378 C4591001 1057 10571378 07DEC2020 21122 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10571379 C4591001 1057 10571379 07DEC2020 21127 Placebo 07DEC2020/ Placebo 30DEC2020/ Placebo 13MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10571380 C4591001 1057 10571380 08DEC2020 21345 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 93 FDA-CBER-2022-5812-0228298 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10571382 C4591001 1057 10571382 08DEC2020 21352 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10571383 C4591001 1057 10571383 08DEC2020 21346 Placebo 08DEC2020/ Placebo 30DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10571384 C4591001 1057 10571384 08DEC2020 21348 Placebo 08DEC2020/ Placebo 28DEC2020/ Placebo 29JUN2021/ BNT162b2 (30 μg)20JUL2021/ BNT162b2 (30 μg) 10571385 C4591001 1057 10571385 08DEC2020 21504 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10571386 C4591001 1057 10571386 08DEC2020 21508 Placebo 08DEC2020/ Placebo29DEC2020/ Placebo 10571387 C4591001 1057 10571387 09DEC2020 21509 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 02JUN2021/ BNT162b2 (30 μg)23JUN2021/ BNT162b2 (30 μg) 10571388 C4591001 1057 10571388 09DEC2020 21512 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10571389 C4591001 1057 10571389 09DEC2020 21705 Placebo 09DEC2020/ Placebo04JAN2021/ Placebo 10571390 C4591001 1057 10571390 09DEC2020 21706 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10571391 C4591001 1057 10571391 09DEC2020 21711 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 24FEB2021/ BNT162b2 (30 μg)17MAR2021/ BNT162b2 (30 μg) 10571392 C4591001 1057 10571392 09DEC2020 21712 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 94 FDA-CBER-2022-5812-0228299 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10571393 C4591001 1057 10571393 09DEC2020 21754 Placebo 09DEC2020/ Placebo 28DEC2020/ Placebo 27MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10571394 C4591001 1057 10571394 09DEC2020 21756 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10571395 C4591001 1057 10571395 09DEC2020 21757 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)14JAN2021/ BNT162b2 (30 μg) 10571396 C4591001 1057 10571396 10DEC2020 21761 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10571397 C4591001 1057 10571397 10DEC2020 21949 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10571398 C4591001 1057 10571398 10DEC2020 21951 Placebo 10DEC2020/ Placebo 30DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)03JUN2021/ BNT162b2 (30 μg) 10571399 C4591001 1057 10571399 10DEC2020 21954 BNT162b2 (30 μg) 10DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10571400 C4591001 1057 10571400 11DEC2020 21956 Placebo 11DEC2020/ Placebo 30DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10571401 C4591001 1057 10571401 11DEC2020 22057 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10571402 C4591001 1057 10571402 14DEC2020 22058 Placebo 14DEC2020/ Placebo 06JAN2021/ Placebo 03MAR2021/ BNT162b2 (30 μg)24MAR2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 95 FDA-CBER-2022-5812-0228300 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10571403 C4591001 1057 10571403 14DEC2020 22059 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10571404 C4591001 1057 10571404 16DEC2020 22062 Placebo 16DEC2020/ Placebo 04JAN2021/ Placebo 28JUN2021/ BNT162b2 (30 μg)21JUL2021/ BNT162b2 (30 μg) 10571405 C4591001 1057 10571405 16DEC2020 22896 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10571406 C4591001 1057 10571406 16DEC2020 22901 Placebo 16DEC2020/ Placebo 05JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10571407 C4591001 1057 10571407 17DEC2020 22903 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 12MAR2021/ BNT162b2 (30 μg)02APR2021/ BNT162b2 (30 μg) 10571408 C4591001 1057 10571408 17DEC2020 23052 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 10571409 C4591001 1057 10571409 17DEC2020 22902 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10571410 C4591001 1057 10571410 17DEC2020 23056 Placebo 17DEC2020/ Placebo 05JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10571411 C4591001 1057 10571411 17DEC2020 23059 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10571412 C4591001 1057 10571412 17DEC2020 23060 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10571413 C4591001 1057 10571413 21DEC2020 23709 BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 96 FDA-CBER-2022-5812-0228301 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10571414 C4591001 1057 10571414 21DEC2020 23710 Placebo 21DEC2020/ Placebo12JAN2021/ Placebo 10571415 C4591001 1057 10571415 21DEC2020 23714 Placebo 21DEC2020/ Placebo 14JAN2021/ Placebo 03JUN2021/ BNT162b2 (30 μg)09JUL2021/ BNT162b2 (30 μg) 10571416 C4591001 1057 10571416 21DEC2020 23716 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10571417 C4591001 1057 10571417 21DEC2020 23793 Placebo 21DEC2020/ Placebo 11JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10571418 C4591001 1057 10571418 22DEC2020 23800 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10571419 C4591001 1057 10571419 22DEC2020 23803 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10571420 C4591001 1057 10571420 23DEC2020 23804 Placebo 23DEC2020/ Placebo11JAN2021/ Placebo 10571421 C4591001 1057 10571421 23DEC2020 24261 Placebo 23DEC2020/ Placebo11JAN2021/ Placebo 10571422 C4591001 1057 10571422 23DEC2020 24265 BNT162b2 (30 μg) 23DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10571423 C4591001 1057 10571423 24DEC2020 24269 BNT162b2 (30 μg) 24DEC2020/ BNT162b2 (30 μg)15JAN2021/ BNT162b2 (30 μg) 10571424 C4591001 1057 10571424 24DEC2020 24271 Placebo 24DEC2020/ Placebo 15JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 97 FDA-CBER-2022-5812-0228302 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10571425 C4591001 1057 10571425 24DEC2020 24301 Placebo 24DEC2020/ Placebo12JAN2021/ Placebo 10571426 C4591001 1057 10571426 24DEC2020 24305 BNT162b2 (30 μg) 24DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10571427 C4591001 1057 10571427 24DEC2020 24306 BNT162b2 (30 μg) 24DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10571428 C4591001 1057 10571428 24DEC2020 24307 Placebo 24DEC2020/ Placebo21JAN2021/ Placebo 10571429 C4591001 1057 10571429 24DEC2020 24309 BNT162b2 (30 μg) 24DEC2020/ BNT162b2 (30 μg)21JAN2021/ BNT162b2 (30 μg) 10571430 C4591001 1057 10571430 29DEC2020 24310 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10571431 C4591001 1057 10571431 30DEC2020 24313 Placebo 30DEC2020/ Placebo 18JAN2021/ Placebo 27MAY2021/ BNT162b2 (30 μg)21JUN2021/ BNT162b2 (30 μg) 10571432 C4591001 1057 10571432 30DEC2020 24314 Placebo 30DEC2020/ Placebo 18JAN2021/ Placebo 13MAY2021/ BNT162b2 (30 μg)01JUN2021/ BNT162b2 (30 μg) 10571433 C4591001 1057 10571433 30DEC2020 25022 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)22JAN2021/ BNT162b2 (30 μg) 10571434 C4591001 1057 10571434 31DEC2020 25023 Placebo 31DEC2020/ Placebo 21JAN2021/ Placebo 10JUN2021/ BNT162b2 (30 μg)29JUN2021/ BNT162b2 (30 μg) 10571435 C4591001 1057 10571435 04JAN2021 25024 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 98 FDA-CBER-2022-5812-0228303 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10571436 C4591001 1057 10571436 04JAN2021 25025 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 22JUL2021/ BNT162b2 (30 μg)17AUG2021/ BNT162b2 (30 μg) 10571437 C4591001 1057 10571437 04JAN2021 25257 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 20JUL2021/ BNT162b2 (30 μg)10AUG2021/ BNT162b2 (30 μg) 10571438 C4591001 1057 10571438 04JAN2021 25260 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10571439 C4591001 1057 10571439 06JAN2021 25263 Placebo 06JAN2021/ Placebo 25JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10571440 C4591001 1057 10571440 06JAN2021 25264 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10571441 C4591001 1057 10571441 06JAN2021 25802 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10571442 C4591001 1057 10571442 07JAN2021 25803 Placebo 07JAN2021/ Placebo 29JAN2021/ Placebo 28MAY2021/ BNT162b2 (30 μg)22JUL2021/ BNT162b2 (30 μg) 10571443 C4591001 1057 10571443 08JAN2021 25806 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10571444 C4591001 1057 10571444 08JAN2021 25808 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10571445 C4591001 1057 10571445 11JAN2021 26531 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10571446 C4591001 1057 10571446 11JAN2021 26533 Placebo 11JAN2021/ Placebo01FEB2021/ Placebo 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 99 FDA-CBER-2022-5812-0228304 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10571447 C4591001 1057 10571447 11JAN2021 26537 Placebo 11JAN2021/ Placebo 01FEB2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10571448 C4591001 1057 10571448 11JAN2021 26539 BNT162b2 (30 μg) 11JAN2021/ BNT162b2 (30 μg)01FEB2021/ BNT162b2 (30 μg) 10571449 C4591001 1057 10571449 12JAN2021 26799 Placebo 12JAN2021/ Placebo 02FEB2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10571450 C4591001 1057 10571450 12JAN2021 26801 Placebo 12JAN2021/ Placebo02FEB2021/ Placebo 10571451 C4591001 1057 10571451 12JAN2021 26802 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10571452 C4591001 1057 10571452 12JAN2021 26804 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 10571453 C4591001 1057 10571453 12JAN2021 26895 Placebo 12JAN2021/ Placebo 01FEB2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10571454 C4591001 1057 10571454 12JAN2021 26891 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)03FEB2021/ BNT162b2 (30 μg) 10661394 C4591001 1066 10661394 09DEC2020 21555 Placebo 09DEC2020/ Placebo 30DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)15JUN2021/ BNT162b2 (30 μg) 10661395 C4591001 1066 10661395 01DEC2020 20590 BNT162b2 (30 μg) 01DEC2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10661397 C4591001 1066 10661397 01DEC2020 20591 Placebo 01DEC2020/ Placebo 22DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 100 FDA-CBER-2022-5812-0228305 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10661401 C4591001 1066 10661401 02DEC2020 20593 Placebo 02DEC2020/ Placebo 21DEC2020/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10661402 C4591001 1066 10661402 02DEC2020 20598 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10661403 C4591001 1066 10661403 03DEC2020 20829 Placebo 03DEC2020/ Placebo 23DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10661404 C4591001 1066 10661404 03DEC2020 20834 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10661405 C4591001 1066 10661405 03DEC2020 20838 Placebo 03DEC2020/ Placebo 22DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10661407 C4591001 1066 10661407 04DEC2020 20840 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10661408 C4591001 1066 10661408 08DEC2020 21549 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10661409 C4591001 1066 10661409 08DEC2020 21550 BNT162b2 (30 μg) 08DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10661410 C4591001 1066 10661410 09DEC2020 21557 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10661411 C4591001 1066 10661411 09DEC2020 21801 BNT162b2 (30 μg) 09DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 101 FDA-CBER-2022-5812-0228306 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10661412 C4591001 1066 10661412 09DEC2020 21808 Placebo 09DEC2020/ Placebo 29DEC2020/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10661414 C4591001 1066 10661414 14DEC2020 21812 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10661415 C4591001 1066 10661415 14DEC2020 21809 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 05JUL2021/ BNT162b2 (30 μg)26JUL2021/ BNT162b2 (30 μg) 10661416 C4591001 1066 10661416 15DEC2020 22668 Placebo 15DEC2020/ Placebo 05JAN2021/ Placebo 25MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 10661417 C4591001 1066 10661417 16DEC2020 22672 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10661418 C4591001 1066 10661418 16DEC2020 22674 Placebo 16DEC2020/ Placebo 05JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)17JUN2021/ BNT162b2 (30 μg) 10661419 C4591001 1066 10661419 16DEC2020 22675 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10661420 C4591001 1066 10661420 17DEC2020 23169 BNT162b2 (30 μg) 17DEC2020/ BNT162b2 (30 μg)05JAN2021/ BNT162b2 (30 μg) 10661421 C4591001 1066 10661421 22DEC2020 23175 Placebo 22DEC2020/ Placebo 13JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)17JUN2021/ BNT162b2 (30 μg) 10661422 C4591001 1066 10661422 22DEC2020 23176 BNT162b2 (30 μg) 22DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 102 FDA-CBER-2022-5812-0228307 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10661423 C4591001 1066 10661423 30DEC2020 23177 Placebo 30DEC2020/ Placebo 26JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)14JUN2021/ BNT162b2 (30 μg) 10661424 C4591001 1066 10661424 30DEC2020 24922 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10661425 C4591001 1066 10661425 05JAN2021 24924 Placebo 05JAN2021/ Placebo 26JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10661426 C4591001 1066 10661426 06JAN2021 24926 Placebo 06JAN2021/ Placebo 28JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10661427 C4591001 1066 10661427 06JAN2021 24930 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10661428 C4591001 1066 10661428 06JAN2021 25737 Placebo 06JAN2021/ Placebo 26JAN2021/ Placebo 15MAR2021/ BNT162b2 (30 μg)05APR2021/ BNT162b2 (30 μg) 10661429 C4591001 1066 10661429 06JAN2021 25738 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 26JUL2021/ BNT162b2 (30 μg)16AUG2021/ BNT162b2 (30 μg) 10661430 C4591001 1066 10661430 07JAN2021 25740 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)26JAN2021/ BNT162b2 (30 μg) 10661431 C4591001 1066 10661431 07JAN2021 25745 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10661432 C4591001 1066 10661432 07JAN2021 25990 Placebo 07JAN2021/ Placebo 26JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 103 FDA-CBER-2022-5812-0228308 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10661433 C4591001 1066 10661433 07JAN2021 25991 Placebo 07JAN2021/ Placebo 26JAN2021/ Placebo 19MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10661434 C4591001 1066 10661434 12JAN2021 25995 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10661435 C4591001 1066 10661435 12JAN2021 25998 BNT162b2 (30 μg) 12JAN2021/ BNT162b2 (30 μg)02FEB2021/ BNT162b2 (30 μg) 10771274 C4591001 1077 10771274 03DEC2020 20843 BNT162b2 (30 μg) 03DEC2020/ BNT162b2 (30 μg)22DEC2020/ BNT162b2 (30 μg) 10771275 C4591001 1077 10771275 03DEC2020 20844 Placebo 03DEC2020/ Placebo 22DEC2020/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10771277 C4591001 1077 10771277 04DEC2020 20846 Placebo 04DEC2020/ Placebo 23DEC2020/ Placebo 24MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 10771278 C4591001 1077 10771278 04DEC2020 20852 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)23DEC2020/ BNT162b2 (30 μg) 10771279 C4591001 1077 10771279 14DEC2020 22249 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10771280 C4591001 1077 10771280 14DEC2020 22250 Placebo 14DEC2020/ Placebo 04JAN2021/ Placebo 28MAY2021/ BNT162b2 (30 μg)18JUN2021/ BNT162b2 (30 μg) 10771281 C4591001 1077 10771281 14DEC2020 22251 BNT162b2 (30 μg) 14DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10771282 C4591001 1077 10771282 14DEC2020 22253 Placebo 14DEC2020/ Placebo05JAN2021/ Placebo 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 104 FDA-CBER-2022-5812-0228309 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10771283 C4591001 1077 10771283 15DEC2020 22476 Placebo 15DEC2020/ Placebo 06JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)08JUN2021/ BNT162b2 (30 μg) 10771284 C4591001 1077 10771284 15DEC2020 22478 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10771285 C4591001 1077 10771285 15DEC2020 22479 Placebo 15DEC2020/ Placebo 07JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10771286 C4591001 1077 10771286 15DEC2020 22483 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)04JAN2021/ BNT162b2 (30 μg) 10771287 C4591001 1077 10771287 15DEC2020 22545 BNT162b2 (30 μg) 15DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10771288 C4591001 1077 10771288 16DEC2020 22554 BNT162b2 (30 μg) 16DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10771289 C4591001 1077 10771289 18DEC2020 22555 Placebo 18DEC2020/ Placebo08JAN2021/ Placebo 10771290 C4591001 1077 10771290 18DEC2020 22556 Placebo 18DEC2020/ Placebo08JAN2021/ Placebo 10771291 C4591001 1077 10771291 18DEC2020 23397 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10771292 C4591001 1077 10771292 18DEC2020 23398 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10771293 C4591001 1077 10771293 18DEC2020 23401 Placebo 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 105 FDA-CBER-2022-5812-0228310 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10771294 C4591001 1077 10771294 28DEC2020 23404 Placebo 28DEC2020/ Placebo 20JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)18JUN2021/ BNT162b2 (30 μg) 10771295 C4591001 1077 10771295 28DEC2020 24443 Placebo 28DEC2020/ Placebo 20JAN2021/ Placebo 25FEB2021/ BNT162b2 (30 μg)17MAR2021/ BNT162b2 (30 μg) 10771296 C4591001 1077 10771296 29DEC2020 24444 BNT162b2 (30 μg) 29DEC2020/ BNT162b2 (30 μg)20JAN2021/ BNT162b2 (30 μg) 10771297 C4591001 1077 10771297 06JAN2021 24445 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)28JAN2021/ BNT162b2 (30 μg) 10771298 C4591001 1077 10771298 07JAN2021 24446 Placebo 07JAN2021/ Placebo 27JAN2021/ Placebo 14MAY2021/ BNT162b2 (30 μg)04JUN2021/ BNT162b2 (30 μg) 10771299 C4591001 1077 10771299 07JAN2021 25979 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10771300 C4591001 1077 10771300 07JAN2021 25982 BNT162b2 (30 μg) 07JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10841541 C4591001 1084 10841541 11DEC2020 22033 BNT162b2 (30 μg) 11DEC2020/ BNT162b2 (30 μg)30DEC2020/ BNT162b2 (30 μg) 10841542 C4591001 1084 10841542 11DEC2020 22034 Placebo 11DEC2020/ Placebo30DEC2020/ Placebo 10841543 C4591001 1084 10841543 18DEC2020 22037 Placebo 18DEC2020/ Placebo 08JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10841544 C4591001 1084 10841544 18DEC2020 22039 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 106 FDA-CBER-2022-5812-0228311 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10841545 C4591001 1084 10841545 18DEC2020 23459 Placebo 18DEC2020/ Placebo 06JAN2021/ Placebo 18MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10841546 C4591001 1084 10841546 18DEC2020 23462 BNT162b2 (30 μg) 18DEC2020/ BNT162b2 (30 μg)06JAN2021/ BNT162b2 (30 μg) 10841547 C4591001 1084 10841547 21DEC2020 23463 Placebo 21DEC2020/ Placebo 13JAN2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10841548 C4591001 1084 10841548 21DEC2020 23465 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10841549 C4591001 1084 10841549 21DEC2020 23666 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10841550 C4591001 1084 10841550 21DEC2020 23669 Placebo 21DEC2020/ Placebo 13JAN2021/ Placebo 02AUG2021/ BNT162b2 (30 μg)25AUG2021/ BNT162b2 (30 μg) 10841551 C4591001 1084 10841551 21DEC2020 23670 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)13JAN2021/ BNT162b2 (30 μg) 10841552 C4591001 1084 10841552 21DEC2020 23671 Placebo 21DEC2020/ Placebo 11JAN2021/ Placebo 24MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10841553 C4591001 1084 10841553 21DEC2020 23853 BNT162b2 (30 μg) 21DEC2020/ BNT162b2 (30 μg)11JAN2021/ BNT162b2 (30 μg) 10841555 C4591001 1084 10841555 21DEC2020 23854 Placebo 21DEC2020/ Placebo 11JAN2021/ Placebo 30JUL2021/ BNT162b2 (30 μg)20AUG2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 107 FDA-CBER-2022-5812-0228312 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10841556 C4591001 1084 10841556 28DEC2020 23862 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10841557 C4591001 1084 10841557 28DEC2020 23860 Placebo 28DEC2020/ Placebo18JAN2021/ Placebo 10841558 C4591001 1084 10841558 28DEC2020 24419 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10841559 C4591001 1084 10841559 28DEC2020 24423 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10841560 C4591001 1084 10841560 28DEC2020 24418 Placebo 28DEC2020/ Placebo 22JAN2021/ Placebo 28MAY2021/ BNT162b2 (30 μg)21JUN2021/ BNT162b2 (30 μg) 10841561 C4591001 1084 10841561 28DEC2020 24428 Placebo 28DEC2020/ Placebo 18JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10841562 C4591001 1084 10841562 28DEC2020 24492 BNT162b2 (30 μg) 28DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10841563 C4591001 1084 10841563 30DEC2020 24494 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10841564 C4591001 1084 10841564 30DEC2020 24497 Placebo 30DEC2020/ Placebo 18JAN2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10841565 C4591001 1084 10841565 30DEC2020 24499 Placebo 30DEC2020/ Placebo 20JAN2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10841566 C4591001 1084 10841566 30DEC2020 24971 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 108 FDA-CBER-2022-5812-0228313 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10841567 C4591001 1084 10841567 30DEC2020 24972 BNT162b2 (30 μg) 30DEC2020/ BNT162b2 (30 μg)18JAN2021/ BNT162b2 (30 μg) 10841568 C4591001 1084 10841568 30DEC2020 24977 Placebo 30DEC2020/ Placebo18JAN2021/ Placebo 10841569 C4591001 1084 10841569 30DEC2020 24979 Placebo 30DEC2020/ Placebo 22JAN2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10841570 C4591001 1084 10841570 30DEC2020 25066 Placebo 30DEC2020/ Placebo 22JAN2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10841571 C4591001 1084 10841571 30DEC2020 25071 Placebo 30DEC2020/ Placebo 20JAN2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)04AUG2021/ BNT162b2 (30 μg) 10841572 C4591001 1084 10841572 04JAN2021 116601 Placebo 04JAN2021/ Placebo 25JAN2021/ Placebo 28MAY2021/ BNT162b2 (30 μg)18JUN2021/ BNT162b2 (30 μg) 10841573 C4591001 1084 10841573 04JAN2021 25075 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10841574 C4591001 1084 10841574 04JAN2021 25076 BNT162b2 (30 μg) 04JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10841575 C4591001 1084 10841575 04JAN2021 25317 Placebo 04JAN2021/ Placebo 27JAN2021/ Placebo 16APR2021/ BNT162b2 (30 μg)07MAY2021/ BNT162b2 (30 μg) 10841576 C4591001 1084 10841576 06JAN2021 25320 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)25JAN2021/ BNT162b2 (30 μg) 10841577 C4591001 1084 10841577 06JAN2021 25326 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 109 FDA-CBER-2022-5812-0228314 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10841578 C4591001 1084 10841578 06JAN2021 25327 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10841579 C4591001 1084 10841579 06JAN2021 25727 Placebo 06JAN2021/ Placebo27JAN2021/ Placebo 10841580 C4591001 1084 10841580 06JAN2021 25728 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10841581 C4591001 1084 10841581 06JAN2021 25729 Placebo 06JAN2021/ Placebo 27JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10841582 C4591001 1084 10841582 06JAN2021 25733 BNT162b2 (30 μg) 06JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10841583 C4591001 1084 10841583 08JAN2021 26194 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10841584 C4591001 1084 10841584 08JAN2021 26195 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10841586 C4591001 1084 10841586 08JAN2021 26196 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10841587 C4591001 1084 10841587 08JAN2021 26202 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 20MAY2021/ BNT162b2 (30 μg)09JUN2021/ BNT162b2 (30 μg) 10841588 C4591001 1084 10841588 08JAN2021 26278 Placebo 08JAN2021/ Placebo 27JAN2021/ Placebo 21MAY2021/ BNT162b2 (30 μg)11JUN2021/ BNT162b2 (30 μg) 10841589 C4591001 1084 10841589 08JAN2021 26277 Placebo 08JAN2021/ Placebo29JAN2021/ Placebo 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 110 FDA-CBER-2022-5812-0228315 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10841590 C4591001 1084 10841590 08JAN2021 26337 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10841591 C4591001 1084 10841591 08JAN2021 26286 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10841592 C4591001 1084 10841592 08JAN2021 26281 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)27JAN2021/ BNT162b2 (30 μg) 10841593 C4591001 1084 10841593 08JAN2021 26341 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10841594 C4591001 1084 10841594 08JAN2021 26343 BNT162b2 (30 μg) 08JAN2021/ BNT162b2 (30 μg)29JAN2021/ BNT162b2 (30 μg) 10841595 C4591001 1084 10841595 08JAN2021 26346 Placebo 08JAN2021/ Placebo 27JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10841596 C4591001 1084 10841596 08JAN2021 26414 Placebo 08JAN2021/ Placebo 29JAN2021/ Placebo 17MAY2021/ BNT162b2 (30 μg)07JUN2021/ BNT162b2 (30 μg) 10841597 C4591001 1084 10841597 08JAN2021 26417 Placebo 08JAN2021/ Placebo 27JAN2021/ Placebo 07MAY2021/ BNT162b2 (30 μg)28MAY2021/ BNT162b2 (30 μg) 10911394 C4591001 1091 10911394 02DEC2020 117070 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 10911395 C4591001 1091 10911395 02DEC2020 20579 BNT162b2 (30 μg) 02DEC2020/ BNT162b2 (30 μg)21DEC2020/ BNT162b2 (30 μg) 090177e1988b7714\Final\Final On: 09-Nov-2021 04:12 (GMT) Page 111 FDA-CBER-2022-5812-0228316 16.1.7 Listing of Randomization Sch eme and Actual Vaccine Received – All Subjects 12 Through 15 Years of Age Vaccine Received Subjecta USUBJID Randomization Date Randomization Number Randomized Vaccine GroupDate/ Dose 1 Date/ Dose 2 Date/ Dose 3 Date/ Dose 4 10911396 C4591001 1091 10911396 02DEC2020 20583 Placebo 02DEC2020/ Placebo 21DEC2020/ Placebo 12MAY2021/ BNT162b2 (30 μg)01JUN2021/ BNT162b2 (30 μg) 10911399 C4591001 1091 10911399 04DEC2020 20586 BNT162b2 (30 μg) 04DEC2020/ BNT162b2 (30 μg)07JAN2021/ BNT162b2 (30 μg) 10911400 C4591001 1091 10911400 04DEC2020 20962 Placebo 04DEC2020/ Placebo 29DEC2020/ Placebo 01JUN2021/ BNT162b2 (30 μg)06JUL2021/ BNT162b2 (30 μg) 10911402 C4591001 1091 10911402 07DEC2020 20966 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10911403 C4591001 1091 10911403 07DEC2020 20967 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)29DEC2020/ BNT162b2 (30 μg) 10911404 C4591001 1091 10911404 07DEC2020 20969 Placebo 07DEC2020/ Placebo28DEC2020/ Placebo 10911405 C4591001 1091 10911405 07DEC2020 21240 Placebo 07DEC2020/ Placebo 28DEC2020/ Placebo 27MAY2021/ BNT162b2 (30 μg)16JUN2021/ BNT162b2 (30 μg) 10911406 C4591001 1091 10911406 07DEC2020 21242 BNT162b2 (30 μg) 07DEC2020/ BNT162b2 (30 μg)28DEC2020/ BNT162b2 (30 μg) 10911407 C4591001 1091 10911407 08DE …[truncated]